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 ABSTRACT 
 
JESSICA MASTRODOMENICO 
An Examination of the Socio-Demographic Characteristics Associated with Adult Vaccination 
Prevalence for Preventable Diseases in the United States 
(Under the direction of Christine Stauber, Faculty Member) 
 
Background:  An estimated 50,000 adults in the United States (U.S.) die each year from one of 
10 vaccine preventable diseases. For those who survive vaccine preventable infections, health 
care costs and loss of income become more significant.  While children in the U.S. aged 0-2 
exhibit vaccine prevalence rates of almost 90%, some adult vaccine prevalence rates in the U.S. 
population are reported to be nearly 30-40% less than the goals set forth by Healthy People 2010.  
The purpose of this study was to examine the associations between socio-demographic 
characteristics of U.S. adults and adult vaccination prevalence for pneumococcal, hepatitis A, 
hepatitis B, tetanus, and pertussis. 
Methods:  Data from the 2008 National Health Interview Survey were assessed examining 
various health indicators and characteristics of non-institutionalized adults and children. The 
sample was restricted to adults ≥18 years of age.  Odds ratios were calculated and multivariate 
logistic regression was also conducted.  P-values of <0.05 and 95% confidence intervals were 
used to determine statistical significance. 
Results:  There were 21781 total observations; 19.3% received the pneumococcal vaccine, 9.4% 
received the hepatitis A vaccine, 27.2% received the hepatitis B vaccine, 55.1% received the 
tetanus vaccine, and 15.2% received the pertussis vaccine.  Of the socio-demographic 
characteristics examined, age, health insurance, marital status, and education were significant for 
either all five or at least four of the vaccines included in this study.  As one might expect those 
who reported health insurance and those who had a higher level of education usually had a 
higher likelihood of vaccine receipt as compared to those without health insurance and those 
with less than a high school education.  Age associations varied due to age-related 
recommendations for certain vaccines such as pneumococcal (recommended for adults ≥65).  
Compared to the married population (referent), marital status results varied, but for reasons 
unclear.  Whites, the referent group, were the most likely to be vaccinated as compared to 
Blacks, Hispanics/Latinos, and Asians.  Hispanics/Latinos typically had the lowest likelihood of 
vaccination in this examination. 
Conclusions:  This study further explores the impact of socio-demographic disparities on 
vaccination status and adds new information to the literature regarding adult vaccination rates for 
preventable diseases.  While research exists related to strengthening interventions such as patient 
reminder systems, those who do not see the same health care providers on a regular basis remain 
at risk for lower vaccination prevalence.  It is important to better understand the role of social 
determinants of health, specifically in terms of vaccinations.  Future research is needed to further 
characterize the association of socio-demographic factors with receipt of optional vaccines in 
adults.
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CHAPTER I 
INTRODUCTION 
 
1.1 Background  
The development and subsequent success of vaccinations has been touted as one of the 
“greatest public health achievements” to date and the science of vaccines accomplished what no 
other science could: the eradication of smallpox and the elimination of polio in the United States 
(U.S.) (André, 2003; Trust for America's Health, 2010; U.S. Department of Health and Human 
Services, 2000).  Vaccines have the ability to prevent infectious diseases and also to reduce the 
morbidity and mortality associated with some diseases.  Currently, there are vaccines available to 
prevent 26 infectious diseases (André, 2003).  However, they often remain under-utilized 
especially when one considers vaccines for adults which are recommended but not required (U.S. 
Department of Health and Human Services, 2000).  It is estimated that approximately 50,000 
adults in the U.S. die annually due to one of 10 vaccine preventable diseases (Marks, 2009; Trust 
for America's Health, 2010).   
Vaccine preventable diseases (VPDs) in the U.S., albeit not the largest public health 
threat, continue to create additional healthcare expenses for and pose significant risks to the 
health of the public (Allen, 2010).  Low vaccination rates are important to address in general; 
however, an interesting combination of challenges arise when one considers the adult population.  
This is a population vulnerable to preventable diseases that are controllable via vaccinations, but 
such vaccinations are not required by law.  In contrast, many vaccine mandates and laws exist 
with regards to the child and adolescent populations in the U.S.  For example, while the specific 
list of required vaccinations can vary per state, children are not allowed to enroll in U.S. schools 
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unless they provide proof of certain immunizations (Zimet, Maehr, Constantine, & English, 
2008).  In the state of Georgia, all children attending either school or childcare must receive a 
full series of the diphtheria, tetanus, pertussis combination vaccine before the age of seven 
(Georgia Department of Human Resources, 2007).  For children younger than seven, parents or 
guardians must prove that children have started the series of shots and are following a particular 
vaccination schedule that will result in full vaccination by approximately 5-6 years of age 
(Georgia Department of Human Resources, 2007).  These requirements have been effective in 
terms of ensuring both proper vaccination rates and subsequent lower morbidity and mortality 
rates amongst these populations (Zimet et al., 2008).  In fact, at the end of the Healthy People 
2010 timeframe it was estimated that more than 90% of children aged 0-2 had received the 
recommended series of vaccinations with the exception of hepatitis B and varicella (U.S. 
Department of Health and Human Services, 2000). 
The success of child immunization practices is positive and it is important to strive to 
achieve similar vaccine coverage rates in adult populations since adults are exposed to many of 
the same VPDs that children face.  Many factors impact the current vaccine coverage for adult 
populations.  For example, healthcare professionals are not required to remind adults of optional 
vaccinations and updates/boosters and as a result many adults are either under-vaccinated or not 
vaccinated at all (Schaffner, 2008).  This creates an interesting cycle because these adults, just 
like children, are at risk for increased morbidity and mortality.  In a 2003 study researchers stated 
that less than 500 child vaccine-preventable deaths were reported annually in the U.S. versus 
nearly 39,000 adult vaccine-preventable deaths (Adult Immunization Consensus Panel, 2003).  
The primary reason attributed to this difference was the strong childhood immunization 
programs versus the lacking immunization rules for adults in the U.S.  Furthermore, because 
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unvaccinated adults can be carriers (symptomatic or asymptomatic) of many VPDs, they pose 
additional infection risks for infants and children who might not yet be fully vaccinated. 
Just as children can transmit diseases to adults (and vice versa), vaccines have the ability 
to protect adults from child disease carriers via herd immunity.  Herd immunity means that even 
though certain groups of people might not be vaccinated, they have immunity from a disease 
because a large enough proportion of the population is vaccinated either by acquired or inherent 
immunization and therefore the overall risk of disease spreading throughout the population is 
low (“Herd Immunity,” 2010).  Herd immunity is important to consider when reviewing the 
benefits of vaccinations for both children and adults as a vaccine not only protects the person 
receiving the vaccine, but it also has the potential to protect surrounding people.  It is plausible to 
state, for example, that if enough of the U.S. child and adult populations were vaccinated against 
pertussis there would be a much lower risk of non-vaccinated individuals contracting pertussis 
due to the effects of herd immunity.  Even with public service announcements that explain the 
benefits of vaccines along with vaccine mandates and/or recommendations, there will always be 
a subset of the population who declines receipt of vaccinations because of religion, personal 
preferences, and certain freedom of choice issues (Poland & Jacobson, 2001).  However, even 
with this subset of the population, as more people become vaccinated the strength of the overall 
herd immunity becomes more protective.  If vaccines are safe, effective, and accessible then one 
needs to consider why the U.S. loses 50,000 adults each year to various preventable diseases. 
In a report by Schaffner (2008), it was stated that there are three primary reasons why 
adults underutilize vaccines:  1) missed opportunities, 2) no national programs for adults, 3) 
public misunderstanding and misconceptions.  In his report, Schaffner also suggested that the 
remedy for the above stated challenges includes more physicians acting more proactively so as to 
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educate and vaccinate their patients.  The Healthy People 2010 report supported Schaffner’s 
work, as it stated that not knowing what immunizations are recommended, lacking immunization 
recommendations from healthcare professionals, and a gap in general knowledge about 
immunizations are all barriers that impede adult immunization rates (U.S. Department of Health 
and Human Services, 2000).  To further elucidate the reasons for low adult vaccination rates, 
another 2008 study stated that independent variables of having a “usual” place of  care and 
having a “usual” healthcare provider were positively associated with receipt of preventive care – 
information that implies continuity of care is associated with adult vaccination rates (Blewett, 
Johnson, B. Lee, & Scal, 2008). 
Reports that discuss a need for healthcare professionals to recommend vaccines along 
with a patient benefit from continuity of care are not scarce.  These results agree with the 
intuitive concept that as a person visits the same healthcare facility over a period of time, an 
adequate medical record will be compiled and trends related to the need for annual screenings 
and vaccination boosters will be more apparent.  As a patient’s anniversary for a certain 
screening or treatment approaches, healthcare facilities can implement a patient reminder system 
so as to encourage the patient to return for his/her regular preventive care.  While the solution of 
encouraging healthcare providers to be more proactive about patient reminders could prove to be 
successful, it does not account for the portion of the population who either has no access to 
healthcare or who does not see the same health care provider each time medical attention is 
needed.  If the reasons adults choose to either decline or not seek out optional vaccinations are 
neither identified nor addressed, the number of annual illnesses and deaths attributed to vaccine 
preventable diseases will not improve. 
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1.2 Purpose of Study  
Vaccine preventable diseases such as pneumonia, hepatitis A and B, tetanus, and 
pertussis can account for significant days of hospitalization, healthcare costs, missed work days, 
and overall morbidity and mortality rates (Trust for America's Health, 2010).  It can be 
hypothesized that if adult vaccination rates for these diseases were to increase, the impact of 
hospitalizations, healthcare costs, missed work days, and overall morbidity could potentially 
decrease.  Even with the proven success and safety of vaccines these vaccines remain 
underutilized in the adult, American population (Allen, 2010; U.S. Department of Health and 
Human Services, 2000).  Vaccines not only protect individuals from infectious disease related 
disability or death, but they also help to protect entire communities by stopping the spread of 
infections amongst the people (U.S. Department of Health and Human Services, 2000).  Existing 
research has shown that both patient reminder systems and healthcare providers’ roles regarding 
vaccination efforts can increase the percent of adults who receive complete vaccine series and 
recommended updates.  While this is important information, this type of intervention does not 
assist those who are not part of a primary care network, those who do not seek regular medical 
care, and those who are under- or un-insured.  The purpose of this examination is to assess what 
socio-demographic characteristics influence adult vaccination receipt and what socio-
demographic characteristics act as barriers to adult vaccination receipt.  Literature related to 
adult vaccination rates must be enhanced and expanded so that public health professionals may 
better understand what interventions to implement in order to increase the prevalence of fully 
immunized adults in the U.S.  This will in turn help the U.S. experience a reduction in vaccine 
preventable disease related morbidity and mortality rates. 
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1.3 Research Questions  
To further investigate the reasons why adults in the U.S. choose to either receive or 
decline vaccines for preventable diseases, the following questions will be examined: 
1. What are the demographic characteristics of individuals who choose to receive 
recommended vaccinations? 
2. What are the socio-demographic characteristics of individuals who choose to receive 
recommended vaccinations? 
3. Do the typical trends of social determinants of health (those who are more educated, 
wealthier, those who are White) also apply to vaccination trends? 
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
The purpose of this study is to analyze the potential association between vaccination 
status (for pneumonia, hepatitis A, hepatitis B, tetanus, and pertussis) and access to healthcare, 
poverty to income ratio, race/ethnicity, age, gender, region of residence, marital status, and level 
of education.  To support the need for this study a review of existing literature will illustrate the 
benefits of adult vaccines, the epidemiology of each vaccine in this examination, and the 
disparities (or determinants of health) that exist in the U.S.  While a lot of progress has been 
made with regards to targeting specific at-risk populations who need optional vaccines, less is 
understood about the characteristics of the general adult population and overall vaccination 
prevalence rates and trends. 
 
2.1 History of Vaccines in the U.S. 
The oldest vaccine with published accounts of use was a vaccine for smallpox in 1798, 
and the first vaccine in the U.S. that was licensed for use was the influenza vaccine in 1945 
(“Vaccine History:  license and/or first manufacture,” 2010).  Since then numerous additional 
vaccines have been developed and licensed for use in both adults and children.  Vaccines are 
broadly regarded as one of the most important advances in medicine, and vaccines have been 
called a “cornerstone” of the success of medicine in general (Baeyens & Michel, 2010).  Even 
the most general literature search will yield reports of the success of vaccines in terms of 
reducing overall incidence of many infectious diseases.  These reductions in incidence appear to 
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be even more impactful when the prevalence of vaccine receipt increases.  For example between 
the years of 1940-1945, approximately 175,000 cases of pertussis were reported per year 
(Atkinson, Wolfe, Hamborsky, & McIntyre, 2009).  After the pertussis vaccine was introduced 
into clinical practice in the mid-1940s, pertussis incidence rates steadily declined and went from 
15,000 cases per year in 1960 to 5,000 cases per year in 1970 to 2,900 cases per year between the 
years of 1980-1990 (Atkinson et al., 2009).   The success of vaccines contributed, in part, to the 
fact that the U.S. no longer considers infectious diseases the primary source of morbidity and 
mortality in the country (Turnock, 2009).  Additionally, vaccines have been included on the list 
of reasons why the life expectancy of adults worldwide has increased (Baeyens & Michel, 2010). 
 
2.2 Healthy People 2010 
Healthy People, an initiative aimed at establishing health objectives for the U.S., was first 
developed after the release of the 1979 Surgeon General’s Report titled “Healthy People: The 
Surgeon General’s Report on Health Promotion and Disease Prevention” (U.S. Department of 
Health and Human Services, 2000).  Subsequent Healthy People editions were released in 1990, 
2000, and 2010.  The Healthy People initiative creates new goals and objectives related to the 
improving the health and reducing health disparities for Americans.  Updated or new goals and 
objectives are published every 10 years and during each decade, progress related to the goals is 
tracked nationwide. 
Healthy People 2010 included 467 objectives within 28 focus areas for residents in the 
U.S.  The overall mission of the 2010 initiative, released in 2000, was to improve the health of 
the American public via prevention efforts focused on the reduction of illness and disability as 
well as the avoidance of premature death (U.S. Department of Health and Human Services, 
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2000).  With that mission in mind, two primary goals were declared:  to increase quality and 
length of life and to eradicate health disparities (U.S. Department of Health and Human Services, 
2000).  In the initiative 10 leading health indicators were selected because they affect the general 
public and because they can be measurably tracked for progress.  Additionally, the leading health 
indicators must also have an ability to influence action. 
The Healthy People initiative lists immunizations as one of the top 10 leading health 
indicators for the nation.  The most recent reports of vaccination levels show significantly 
different accomplishments for children versus adults (Trust for America's Health, 2010; U.S. 
Department of Health and Human Services, 2000).  The results of Healthy People 2010 indicate 
that while definite progress has been made, the U.S. did not accomplish its immunization goals 
overall.  For example, the goal for pneumococcal vaccine coverage of adults in the U.S. was set 
at 90% yet as of 1998, only 46% of this population reported receipt of the vaccine (U.S. 
Department of Health and Human Services, 2000).  Additionally, the Healthy People 2010 goals 
for DTap (diphtheria, tetanus, and pertussis), polio, MMR (measles, mumps, rubella), and Hib 
(Haemophilus influenzae type b) vaccine coverage were set at 80% of the population, yet as of 
1998 only 73% of the population received these vaccines (U.S. Department of Health and 
Human Services, 2000).  These incomplete immunization outcomes illustrate the divide between 
what vaccines are recommended for adults and what vaccines adults are actually receiving.   
 
2.3 Social Determinants of Health 
Along with immunization goals the Healthy People 2010 report also focused on 
disparities, or social determinants of health, that negatively affect health in general such as: 
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race/ethnicity, gender, income, educational attainment, and access to health care/health insurance 
(U.S. Department of Health and Human Services, 2000).  While these social determinants of 
health exist in general terms, they also exist specifically in terms of immunization rates.  For 
example, much research has been conducted regarding racial differences and vaccination 
prevalence.  During a focus group study in San Francisco, California researchers addressed 
attitudes about vaccination and found that African Americans were less trusting of vaccines and 
healthcare in general as compared to any other race (N. A. Daniels, Juarbe, Rangel-Lugo, 
Moreno-John, & Pérez-Stable, 2004).  Additionally, the Adult Immunization Consensus Panel 
developed a report specifically addressing immunization rates in African-American adults 
because there was such a noted difference in both their use of health care as well as their 
immunization rates (Adult Immunization Consensus Panel, 2003).  In a study that addressed 
issues of immunization and inner-city populations, a racial disparity was noted for pneumococcal 
vaccination rates in older adults (Nowalk, Zimmerman, Tabbarah, Raymund, & Jewell, 2006). 
There is vast research demonstrating the various health disparities experienced in the U.S.  
The Healthy People 2010 report detailed the following examples of certain health disparities:  on 
average, women in the U.S. live 6 years longer than men even after adjusting for genetic 
rationale.  Race/ethnicity remains a disparity as death attributed to heart disease affects 40% 
more African Americans than Caucasians.  There is a positive relationship between income and 
health status, meaning those who earn less money tend to be in poorer health.  A similar pattern 
holds true for level of education achieved in that those with higher educational attainment tend to 
have better health statuses.  People with disabilities tend to have less access to medical care or to 
medical services.  Geographic location continues to be a disparity as we note residents in rural 
areas of the U.S. experience 40% more injury-related deaths as compared to their counterparts in 
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urban environments.  Finally, in terms of sexual orientation, males in the United States who 
identify as homosexuals have a 2-3 times increased risk of attempting suicide as compared to 
their heterosexual counterparts. 
In order to properly address these disparities as well as any trends related to the 
vaccination rates in this examination, it is important to first understand the diseases:  their 
infectious agents, their transmission routes, the associated symptoms (acute and long term), the 
applicable treatments available, and prevention – specifically their related vaccines.  
Additionally, it is important to grasp the burden of each disease in terms of prevalence rates 
within the U.S. along with how vaccines have affected prevalence rates over time. 
 
2.4 Pneumonia 
Pneumococcal disease can result in pneumonia, bacteremia, or meningitis (Atkinson et 
al., 2009).  Pneumococcal pneumonia is the most common syndrome of pneumococcal disease 
infection and community-acquired pneumonia, regardless of age, is most often attributed to 
infection from pneumococcal disease bacteria (Atkinson et al., 2009; Heymann, 2008).  
Pneumococcal pneumonia is also often a secondary complication from influenza or measles 
infection (Atkinson et al., 2009).  For the purposes of this examination, we will focus primarily 
on pneumococcal pneumonia instead of bacteremia or meningitis. 
In 2006 in the United States, the Centers for Disease Control and Prevention stated that 
1.2 million people were hospitalized due to pneumonia and 55,477 people died from pneumonia 
(Centers for Disease Control and Prevention, 2009).  Each year it is estimated that 30-100 cases 
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of pneumonia per 100,000 people occur across Europe and North America and 10,000-14,000 
people in the U.S. die from pneumococcal disease (Heymann, 2008; U.S. Department of Health 
and Human Services, 2000).  Pneumonia primarily affects the elderly population, infants, and 
those with certain pre-existing conditions such as cardiovascular disease, diabetes, cirrhosis, HIV 
infection, and chronic renal failure (Heymann, 2008).  While antibiotic treatment for 
pneumococcal pneumonia exists, studies have shown there is an approximate case-fatality rate of 
5-7% for community-acquired pneumonia; this number is likely to significantly increase when 
only focusing on those most at risk such as the elderly (Atkinson et al., 2009; Marks, 2009).   In 
addition to potential treatment, there is growing concern for infection with antibiotic resistant 
organisms.  Recently researchers estimated that up to 40% of the pneumococcal isolates in the 
U.S. are resistant to penicillin therefore requiring stronger antibiotics to treat these infections 
(Atkinson et al., 2009). 
The bacteria of pneumococcal disease, Streptococcus pneumonia, has at least 90 
serotypes and 10 of the most commonly found serotypes account for an estimated 62% of 
pneumococcal disease globally (Atkinson et al., 2009).  S. pneumonia can be found in the upper 
respiratory tract, most commonly in the nasopharynx, and is often found in otherwise healthy 
humans (Heymann, 2008, p. 473).  As a result, many people are able to transmit the disease even 
though they are asymptomatic.  The rate of asymptomatic carriage of S. pneumonia can vary 
depending on multiple socio-demographic and health status characteristics (Atkinson et al., 
2009).  For example, military establishments note the highest rate of asymptomatic carriers, with 
students and orphanages following a close second (Atkinson et al., 2009).  Adults with no 
children seem to have the lowest rate of asymptomatic carrying, but more research is needed to 
better understand these trends (Atkinson et al., 2009). 
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Once a person is a carrier for S. pneumonia, pneumococcal pneumonia can easily be 
transmitted via droplet spread from sneezing, coughing, and general close human contact 
(Heymann, 2008).  While large outbreaks of pneumonia are not common, they are possible, and 
they most often occur in overcrowded environments such as nursing homes, hospitals, 
correctional facilities, and military bases (Atkinson et al., 2009).  The combination of 
asymptomatic carriers along with the ease of disease transmission is concerning in terms of the 
potential rate of new pneumonia cases each year. 
Pneumococcal pneumonia infects the lungs and symptoms include high fever, chest pain, 
dyspnea, malaise, weakness, and a “rusty” sputum producing cough (Atkinson et al., 2009; 
Marks, 2009).  Onset of symptoms is usually sudden; however, the elderly population sometimes 
experiences a more gradual onset.  Along with the acute symptoms, additional complications 
from pneumonia infections are possible and include:  infections of the pleural space, pericarditis, 
and even lung abscesses (Atkinson et al., 2009).  Pneumonia can affect people of all ages, but as 
per usual with many illnesses, certain populations are at higher risk such as: children, the elderly, 
and those with compromised immune systems (Heymann, 2008). 
The U.S. licensed the first pneumococcal disease vaccine in 1977.  This original vaccine 
addressed 14 serotypes of pneumococcal disease.  It was replaced by a new version in 1983 
(Atkinson et al., 2009).  The 1983 vaccine, named PPSV23 (Pneumovax 23 by Merck and 
Company, and Pnu-Immune 23 by Lederle Laboratories) was designed to protect against 23 
types of pneumococcal bacteria; however, it is important to note that it is more effective against 
pneumococcal bacteremia versus pneumonia (Atkinson et al., 2009).  According to the CDC, 
PPSV23 is recommended for all adults over the age of 65 who have not received previous doses.  
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The vaccine is also safe for people between the ages of 2 - 65 as well as who are at an increased 
risk for the disease due to compromised immune systems, residence at long-term care facilities, 
and those with certain pre-existing conditions (Marks, 2009).  PPSV23 antibody levels remain 
constant for approximately 5-10 years and revaccination is not typically recommended, though 
this can vary depending on the person’s age at time of initial vaccination as well as the person’s 
health status (MMWR, Centers for Disease Control and Prevention, 1997).  The PPSV23 vaccine 
has proven to be successful and CDC estimates that the PPSV23 vaccine prevents approximately 
60-70% of pneumonia cases in adults who are vaccinated (Marks, 2009).   
While the purpose of this examination focuses on adults, it should be noted that an 
additional pneumococcal vaccine for children was released in 2000.  This vaccine, PCV7, 
protects against seven serotypes of S. pneumonia and is recommended for children under 24 
months as well as children between 24-59 months who have pre-existing conditions (Atkinson et 
al., 2009).  The PCV7 vaccine for children has had a positive effect on the adult population, 
because as children are vaccinated, the chance of them passing the disease to surrounding adults 
decreases and therefore less adults become infected (Schaffner, 2008). 
The pneumococcal vaccination is underutilized (Allen, 2010).  After tracking vaccination 
rates from 1991-1998, a Healthy People report estimated that only about 46% of the U.S. 
population over the age of 65 received the pneumococcal disease vaccine (U.S. Department of 
Health and Human Services, 2000).  When the Healthy People 2010 goals were set in 2000, the 
hope was that after a ten year effort to increase vaccine coverage, 90% of adults over 65 years of 
age would be vaccinated against pneumococcal disease (U.S. Department of Health and Human 
Services, 2000).  While the exact numbers vary, current estimates suggest that the Healthy 
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People 2010 goal was not met.  In fact, some studies show that these vaccination rates fell nearly 
30% short of the 2010 goal (Marks, 2009).  Given the number of public health efforts to 
vaccinate people against pneumococcal disease, especially the efforts aimed at ensuring the 
elderly population is vaccinated, reasons for the unmet Healthy People 2010 goals remain 
unclear. 
 
2.5 Hepatitis A 
Before the 1940s there was no distinction between hepatitis A and hepatitis B; however, 
around 1940 new serologic tests enabled researchers to define a difference between the two 
disease types (Atkinson et al., 2009).  While hepatitis A is not consistently prevalent in the U.S. 
this country experiences an epidemic approximately once every decade (Heymann, 2008).  
Hepatitis A became a reportable disease in 1966 and in 1971 the U.S. experienced a record 
breaking (high) number of 59,606 reported cases in a single year (Atkinson et al., 2009).  
Between the years 1987-1997 hepatitis A was named one of the U.S.’ most frequently reported 
diseases from the notifiable diseases list, and during this time the U.S. experienced an average 
28,000 hepatitis A cases (D. Daniels, Grytdal, & Wasley, 2009). 
Hepatitis A is caused by Hepatitis A Virus (HAV), a virus that is transmitted via a fecal-
oral route.  This can be a result of direct human contact and lack of hygiene as well as a result 
due to poor water or food quality; the latter being more common in developing nations with 
inherent water and food quality challenges.  From 1990-2000 the most frequent source of 
infection in the U.S. was reported as “unknown” (45%); however, of those who were able to 
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identify the source of infection the most common transmission route was via sexual and/or 
household contact with an infected person (14%) (Atkinson et al., 2009). 
Symptoms of hepatitis A include fever (with quick onset), malaise, lack of appetite, 
abdominal pain, darkened urine, and jaundice.  When symptoms are present they can last up to 
six months with an average duration of two months (Atkinson et al., 2009; Heymann, 2008).  
Given the potentially long duration of these debilitating symptoms, hepatitis A infection has the 
potential to be significant in terms of lost wages, funds spent on prolonged medication for 
treatment, hospitalization, and other medically-related expenses.  In fact studies have suggested 
that approximately 11-22% of people who contract hepatitis A become hospitalized, resulting in 
unexpected healthcare costs as well as time spent unable to work or take care of daily life 
activities (Atkinson et al., 2009). 
A vaccine for hepatitis A was introduced in 1995 at which point, it was recommended for 
international travelers (Atkinson et al., 2009).  The vaccine consists of two injections; one initial 
shot and one booster dose (Atkinson et al., 2009; D. Daniels et al., 2009; Heymann, 2008).  In 
1996 Advisory Committee on Immunization Practices (ACIP) expanded the recommendation for 
hepatitis A vaccine to include men who have sex with men as well as drug users (D. Daniels et 
al., 2009).  In 1999, ACIP once again the broadened the hepatitis A vaccination 
recommendations to include all children older than two years of age who lived in areas of the 
U.S. where annual hepatitis A rates were two times higher than the national average (listed as 
prevalence rates ≥ 20 cases per 100,000 people) (Atkinson et al., 2009).  ACIP again updated its 
recommendations so that as of 2005, all children in the U.S. between the ages of 12-23 months 
would be vaccinated (D. Daniels et al., 2009; Heymann, 2008).  This plan also included catch-up 
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guidelines for children 2 years or older who were not yet vaccinated.  The hepatitis A vaccine 
became part of the routine child vaccination plan as of 2006 (D. Daniels et al., 2009). 
In a recent publication from the Morbidity and Mortality Weekly Report, incidence of 
hepatitis A experienced a significant decline, as rates went from 12/100,000 people to 1/100,000 
people between 1995-2007 (D. Daniels et al., 2009).  This report also stated that the 2007 
hepatitis A incidence rates were the lowest that the U.S. has ever experienced (D. Daniels et al., 
2009).  There are currently two forms of the hepatitis A vaccine available in the U.S. and their 
efficacy in terms of preventing hepatitis A infection ranges from 94%-100% (Atkinson et al., 
2009).  It is estimated that the vaccine remains protective for at least 20 years; however, because 
the vaccine has only been in existence since 1995 additional research regarding long-term 
efficacy is currently underway (Atkinson et al., 2009).  Per the aforementioned statistics, it is 
appears that the hepatitis A vaccination efforts in general have been successful; however, the 
published rates of hepatitis A incidence do not distinguish between adult versus child cases.  
Therefore it remains unclear as to whether adults are either appropriately or under-vaccinated. 
 
2.6 Hepatitis B 
The CDC estimates that 2 billion people throughout the world have been infected with 
the hepatitis B virus at some point in their lives and that 350+ million people suffer from chronic 
infection (Atkinson et al., 2009).  In the U.S., most adult acute hepatitis B infections are 
resolved, although the long term potential complications can remain. It has been stated that each 
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year the U.S. sees 5,000-8,000 new cases of chronic hepatitis B and that the adult population 
accounts for 95% of new cases (Atkinson et al., 2009). 
Hepatitis B is caused by the hepatitis B virus (HBV), a virus that can be transmitted 
either via a perinatal route or via bodily fluids such as blood and serum.  HBV is also known to 
penetrate mucosal surfaces, therefore allowing infections to occur not only from obvious routes 
such as needle sticks/sharing and sexual contact, but also from hand-to-eye or mucosal lesion 
contact with an infected source of blood or bodily fluid (Atkinson et al., 2009; Heymann, 2008).  
In the U.S. the most commonly reported route of transmission is via sexual contact (Atkinson et 
al., 2009).  Even though injection drug use accounts for only 15% of the primary risk factors 
associated with hepatitis B infection, this risk factor can be quite significant over time.  After one 
year of injection drug use, approximately 40% of drug users will become infected with the virus 
and after 10 years of drug use, approximately 80% of drug users will become infected with the 
virus (Atkinson et al., 2009).  
Symptoms of acute hepatitis B infection include general malaise (which can last for 
weeks and months), vomiting, upper abdominal pain towards the right side of the body, and skin 
rashes.  Jaundice often occurs after the aforementioned symptoms appear, followed by light or 
gray stools and hepatic tenderness (Atkinson et al., 2009).  There is no specific treatment for 
hepatitis B other than management of symptoms and monitoring of a patient’s overall health 
(Heymann, 2008).  It should be noted that in approximately 50% of adults, acute infection is 
asymptomatic.  Aside from chronic symptoms in some patients, other long-term effects of 
hepatitis B include cirrhosis of the liver and hepatocellular carcinoma.  In fact, hepatitis B is 
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attributed to approximately 80% of the global burden of hepatocellular carcinoma (Heymann, 
2008). 
In 1982 the first hepatitis B vaccine was released.  There are now two types of hepatitis B 
vaccines available, including a combination hepatitis B/hepatitis A vaccine option (Heymann, 
2008).  The hepatitis B vaccine includes a series of three shots and a person is not considered 
fully immunized until the full series has been completed (Heymann, 2008).  The vaccines have 
been shown to protect against hepatitis B infections for at least 15 years and there is no schedule 
or recommendation for re-vaccination once a full series of the vaccine has been administered 
(Atkinson et al., 2009).  The hepatitis B vaccines have proven efficacy; however, their impact 
has not been as drastic as researchers originally hoped since targeting the highest risk 
populations (injection drug users, heterosexuals with multiple partners, and men who have sex 
with men) is difficult (Atkinson et al., 2009).  Therefore, in order to eliminate hepatitis B 
transmission the U.S. now recommends the following:  screening for HBV in pregnant women 
and subsequent treatment for newborns; full immunization for at risk populations based on 
employment hazards (i.e. healthcare or laboratory workers) and sexual habits; immunization for 
all infants; and catch up immunization plans for any adolescents who did not complete a 
vaccination series during infancy (Heymann, 2008).  It has been shown that countries with a high 
rate of infant hepatitis B vaccination coverage exhibit the largest decline of hepatitis B incidence 
and prevalence rates (Heymann, 2008).   
 
2.7 Tetanus 
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Tetanus is one of the most serious preventable diseases in this examination, as fatality 
rates are often high depending on the person and the environment.  It has been reported that 11% 
of all reported tetanus cases result in death and that number increases for those over the age of 60 
and for those who are not vaccinated (Atkinson et al., 2009).  Some of the tetanus-related deaths 
can be attributed to secondary issues such as nosocomial infections and pulmonary embolisms, 
but 20% of all tetanus deaths are due to the tetanus toxin (Atkinson et al., 2009).  Tetanus is most 
often noted in environments that are hot and humid, as well as those that have soil which 
contains high concentrations of organic matter (Atkinson et al., 2009). 
Tetanus is caused by the bacteria Clostridium tetani, a naturally occurring and spore-
forming bacterium found in soil, animal feces, some skin surfaces, and heroin that has been 
contaminated (Atkinson et al., 2009).  C. tetani produces two toxins, but the primary fatal toxin 
is called tetanospasmin.  Tetanospasmin is a neurotoxin that causes severe symptoms and 
complications when introduced to an under-vaccinated or non-vaccinated human.  
Tetanospasmin is lethal and CDC states that a dose of 2.5ng/kg of tetanospasmin can kill a 
human weighing approximately 70 kg (or 154lbs) (Atkinson et al., 2009).  Transmission of C. 
tetani from the environment into the human body typically occurs via a bodily wound.  This can 
be a result of an accident or other injury as well as via needles used for injection drug “popping” 
– a process in which a drug, often heroin, is injected just under the skin (Atkinson et al., 2009).  
A tetanus infection and subsequent potential tetanus-related death is not because of the bacteria 
alone, but rather, is attributed to the bacteria’s production of the tetanospasmin toxin (Atkinson 
et al., 2009; Heymann, 2008).  
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Symptoms of an acute tetanus infection include lockjaw, muscle contractions or rigidity, 
muscle spasms, difficulty with swallowing, and seizures.  Muscle spasms can last for 3-4 weeks 
and longer term effects such as hypertension, sepsis from catheters, and other nosocomial 
infections are secondary risks.   Treatment for a tetanus infection includes wound cleaning, 
removal of necrotic tissue as applicable, and other therapies to address muscle spasms and 
airway restriction challenges.  Additionally, tetanus immune globulin (TIG) can be administered 
which helps the body rid itself of any tetanospasmin toxin that has not yet bound to nerve 
endings.  It does not, on the other hand, remove any toxin that has already bound itself to nerve 
endings or reverse the toxin’s negative affects (Atkinson et al., 2009).  Once the person’s health 
is stable the tetanus vaccine should also be administered to protect against future infections.  
The tetanus vaccine was first added to the routine child immunization schedule in the 
1940s, when 0.4 cases per 100,000 people were diagnosed with tetanus in the U.S. annually 
(Atkinson et al., 2009).  In 2003, the U.S. experienced the lowest number of reported cases in 
history:  0.01 cases per 100,000 people.  Almost all of the reported cases of tetanus in the U.S. 
can be linked to people who are either not vaccinated, or, people who are overdue for a booster 
shot.  The initial vaccination schedule includes 4 doses between 2-18 months of age.  The 
primary vaccine used is a combination vaccine that includes protection against diphtheria, 
tetanus, and pertussis.  The initial vaccination schedule can vary depending on the age at which a 
child receives his first dose of the vaccine.  A vaccine without pertussis may also be used if the 
child has an adverse reaction to the pertussis vaccine.  A booster dose of tetanus and diptheria is 
needed every 10 years to ensure proper immunization levels exist.  While the recommendations 
for tetanus vaccination and subsequent boosters every 10 years are clear, the process of 
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reminding patients to receive their boosters remains a challenge (Jacobson Vann & Szilagyi, 
2008). 
 
2.8 Pertussis 
In countries where the vaccine is either unavailable or not used widespread, pertussis 
causes a significant number of deaths annually (Atkinson et al., 2009).  In the U.S. pertussis has 
had a curious pattern of incidence, as it is one of the only vaccine preventable diseases 
experiencing a rise in incidence (Judelsohn & Koslap-Petraco, 2007).  Pertussis was one of the 
primary causes of child mortality until the development of a vaccine in the 1940s (Atkinson et 
al., 2009).  In the 1960s the U.S. noted approximately 8 pertussis cases per 100,000; this number 
decreased to 5 per 100,000 in 1970 and during the 1980-1990 decade, the U.S. saw 
approximately 1 case per 100,000 people (Atkinson et al., 2009; Heymann, 2008).  Overall, it is 
estimated that the incidence of pertussis has decreased by at least 80% since the development of 
a vaccine(Atkinson et al., 2009); however, since the 1980s the incidence of pertussis cases has 
started to increase and in 2004 the nation witnessed the highest number of cases (25,827 cases) 
since 1959 (Atkinson et al., 2009).  While some researchers attribute at least a portion of this 
increase in reported cases to better diagnostic, surveillance, and reporting tools no definitive 
reason for this increased incidence has been identified (Atkinson et al., 2009; Judelsohn & 
Koslap-Petraco, 2007). 
Pertussis is caused by the bacteria Bordetella pertussis which is a toxin-releasing 
bacterium.  Transmission occurs via contact with respiratory droplets, either directly or indirectly 
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via airborne droplets.  The toxins excreted from B. pertussis paralyze the cilia in the human 
respiratory tract and also cause inflammation; both actions therefore making it difficult for a 
person’s respiratory system to tolerate and rid itself of secretions and mucus.  This lessened 
ability to clear secretions and mucus results in an initial round of symptoms similar to a cold:  
sneezing, runny nose, mild fever, and mild cough.  These symptoms increase in severity and the 
mild cough transitions to one that is episodic, often involving thick mucus that is difficult to 
expel and that creates shortness of breath for the patient.  Additionally, after some of the 
coughing episodes, a “high-pitched whoop” can be heard (Atkinson et al., 2009, p. 200).  
Sometimes the coughing attacks are either frequent or violent enough to result in vomiting.  
Coughing attacks are more common during the night hours, so general malaise and exhaustion 
often accompany a pertussis infection. 
Infected adults often encounter a milder form of pertussis but it is important to keep in 
mind that anyone infected with pertussis (regardless of the severity of the infection) is able to 
infect others – especially those who are either under or not vaccinated.  The CDC has stated that 
in a household where more than one pertussis case is identified, the source case is often the older 
person in that household (Atkinson et al., 2009).  In terms of treatment for pertussis, supportive 
therapy is the most common plan and patients are monitored so that undesirable symptoms can 
be managed.  Antibiotics are sometimes administered in order to reduce communicability and 
duration of disease, but this is not always effective.  Antibiotics are more often administered as a 
prophylaxis to the close contacts of the pertussis case (Sandora, Gidengil, & G. M. Lee, 2008).   
The first pertussis vaccine was introduced in the 1940s, but many newer vaccines have 
emerged since then.  Each version of the vaccine differs only in that it has varying levels of 
24 
 
concentrations which are applicable to specific age groups.  All pertussis vaccines are of the 
combination variety and are mixed with tetanus and diphtheria vaccines.  The child schedule for 
pertussis vaccinations includes 4 series of injections between the ages of 2-18 months.  
Depending on the type of vaccine administered and the schedule followed, booster shots are 
sometimes needed when the child enters school – typically between the ages of 4-6.  After the 
initial series is completed, a booster shot is usually recommended between the ages of 11-12 
years and adults who might not have received pertussis vaccines as children should consider a 
booster shot between the ages of 19-64 (Atkinson et al., 2009; “CDC Features - Pertussis 
(Whooping Cough) – What You Need To Know,” 2009; Heymann, 2008).  Healthcare workers 
are classified as a priority group when considering pertussis vaccination since they are at a 
higher risk of infection due to patient contact, and since they could also transmit the disease to 
their patients (Sandora et al., 2008).  This same recommendation holds true for those in close 
contact with infants younger than one year of age (Brooks & Clover, 2006). 
 
2.9 Summary 
Even though the aforementioned diseases are all unique they have one primary 
commonality:  they are preventable via safe and effective vaccines available in the U.S.  
Organizations such as CDC have prepared multiple vaccination schedules, as seen in the 
modified recommended immunization schedule for adults (Figure 1) below.  While the 
recommendations are clear to researchers and scientists, the fact that vaccination rates for U.S. 
adults remain lower than expected begs the question as to whether these recommendations are 
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also clear to the general public.  It is imperative that more research is done to investigate the 
reasons for low vaccination rates so that better interventions can be designed. 
 
 
Figure 1. U.S. recommended adult immunization schedule, 2010 
Vaccine Age Group (years) 
 19-26 27-49 50-59 60-64 ≥65 
Tetanus, diphtheria, 
pertussis  (Td/Tdap) 
Td booster every 10 years; substitute one dose Tdap 
for Td booster. 
Td booster 
every 10 years 
Pneumococcal 
 
1 or 2 doses 1 dose 
Hepatitis A 
 2 doses  
Hepatitis B 
 
3 doses  
   
(Adapted from CDC Vaccines & Immunizations webpage, 2010) White  = recommended 
Gray   = recommended if 
additional risk factor is 
present (medical, 
occupational, lifestyle) 
 
 
 
 
 
 
 
 
26 
 
Chapter III  
METHODOLOGY 
 
3.1 Data Source 
The data used in this study were obtained from the National Health Interview Survey 
(NHIS), a publicly available database that contains de-identified information.  The NHIS is part 
of the National Center for Health Statistics (NCHS), a division of the Centers for Disease 
Control and Prevention (CDC).  The NHIS first began in July of 1957 as a result of the 1956 
National Healthy Survey Act.  This act  “provided for a continuing survey and special studies to 
secure accurate and current statistical information on the amount, distribution, and effects of 
illness and disability in the U.S. and the services rendered for or because of such conditions” 
(National Center for Health Statistics, 2010).  The NHIS collects information from the U.S. non-
institutionalized and civilian population.  NHIS’ primary goal is to monitor the health of the U.S.  
The sampling design of the NHIS is based on each decennial census and updated as needed.  The 
sampling design begins with 428 primary sample units (PSU’s) which represent a county, a 
combination of neighboring counties, or a metropolitan statistical area.  Overall, the PSU’s 
represent the 50 States in the U.S. as well as the District of Columbia. Additionally, each PSU is 
divided into two partitions:  area segments and permit segments.  Area segments are delineated 
via geographic cut points and permit segments focus on housing units.  This is done to ensure 
that multiple family dwellings such as apartment complexes are not under-represented in the 
overall sample. 
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It is important to keep in mind that the NHIS includes an oversampling process for the 
Black, Asian, and Hispanic/Latino populations.  This is managed via an initial oversampling plan 
for certain area segments within a PSU.  Oversampling is also accomplished via a screening 
process during the time of a household interview.  If the household does not have one or more 
Black, Hispanic/Latino, or Asian person that interview is stopped and the household is 
considered “screened out”.  NHIS also oversamples the elderly portion of these groups so that 
adults aged ≥65 in the Black, Hispanic/Latino, or Asian populations are adequately represented.  
Along with oversampling, NHIS implemented weighting methodology.  The 2008 NHIS sample 
included 29,421 families in 28,790 households with a total of 74,236 people.  Of the total 
number of people, 29,421 were eligible to complete the Sample Adult questionnaire.  A total of 
21,781 adults completed these questionnaires.  In order to ensure this sample was representative 
of the nation, data for certain variables were weighted accordingly. 
Surveys are conducted continuously throughout each year and data become available to 
the public annually.  Surveys are conducted by trained interviewers who are employees of the 
U.S. Bureau of the Census.  Surveys contain two main sections: a Core questionnaire and a 
Supplemental questionnaire.  The Core questionnaire is subdivided into an overall household 
section, a family section, a sample adult section, and a sample child section.  The two “sample” 
sections are completed by one adult and one child within the household and the questions are 
based on more of an individual concept than a family or household concept.  The Core 
questionnaire addresses basic information such as demographics and health status.  The 
Supplemental questionnaire allows for the reporting of new public health data as needed.  
Examples of Supplemental data include Healthy People 2010 data, complementary and 
alternative medicine data, and children’s mental health data.  Survey data is collected onsite via a 
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computer assisted personal interviewing (CAPI) process – in other words, a person completing a 
survey enters his or her answers directly into a laptop computer provided by the interviewer. 
NHIS presents the data online in ASCII format.  Users are able to download the files and 
input them into a variety of statistical software programs.  Sample syntax files for SPSS, SAS, 
and STATA are provided on the NHIS website.  For this examination, data files were 
downloaded from the NHIS website and converted to Statistical Package for Social Sciences 
(SPSS)
®
 version 17.0 files.  SPSS 17.0 was used for all analytics in this examination. 
 
3.2 Study Population 
The NHIS includes the civilian and non-institutionalized population residing in the U.S. 
at the time of the survey.  Adults and dependents who reside in a household with an active 
member of the Armed Forces are able to be included in the survey; however, the active military 
person is excluded.  Along with the incarcerated and active duty military populations, patients in 
long term care facilities and U.S. citizens who reside in other countries are also excluded from 
the survey.  Age is not an exclusion factor, except in the case of a sample adult or sample child 
questionnaire.  In these cases, age becomes an important inclusion factor though it should be 
noted that with regards to the sample child questionnaire, an adult in the household is allowed to 
answer on behalf of a minor, if that preference exists.  Survey participation is voluntary and 
confidential. 
In this examination data from 2008 were used; specifically the household, family, person, 
and sample adult files.  Adults greater than or equal to 18 years of age were the only respondents 
included in the final dataset.  No other exclusions were applied.   
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3.3 Study Measures 
The primary dependent variable for this analysis was receipt of vaccination, which was 
analyzed by specifically looking at five different vaccines:  hepatitis A vaccine, hepatitis B 
vaccine, pneumococcal disease vaccine, tetanus vaccine, and pertussis vaccine.  To address these 
dependent variables, subjects were typically asked if they had ever received each of these 
vaccines.  In the case of hepatitis A and B, subjects were also asked to quantify how many shots 
they received if they responded “yes” to whether they had ever received the vaccine.  Finally, 
pertussis vaccination status was asked only to those who had answered affirmatively to the 
receipt of a tetanus shot within the past 10 years.  This is because the pertussis vaccination never 
stands alone and if offered, is always in combination with tetanus and/or tetanus and diphtheria.   
The socio-demographic independent variables used in this study were as follows:  race, 
gender, age, health insurance status, region of the U.S., marital status, education, and poverty to 
income ratio.  Details related for each independent variable including coding are listed in Table 
1.  Additional information regarding the specific states per region of the U.S. variable can be 
seen in Figure 2 below. 
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Figure 2. Map of the U.S. with NHIS grouping of regions. 
 
 
Northeast:  Maine, Vermont, New Hampshire, Massachusetts, Connecticut, Rhode Island, New 
York, New Jersey, Pennsylvania. 
South: Delaware, Maryland, District of Columbia, West Virginia, Virginia, Kentucky, 
Tennessee, North Carolina, South Carolina, Georgia, Florida, Alabama, Mississippi, 
Louisiana, Oklahoma, Arkansas, Texas 
Midwest:  Ohio, Illinois, Indiana, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North 
Dakota, South Dakota, Kansas, Nebraska 
West:  Washington, Oregon, California, Nevada, New Mexico, Arizona, Idaho, Utah, Colorado, 
Montana, Wyoming, Alaska, Hawaii 
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Table 1.  Socio-demographic variables and coding 
Variable Coding 
Race 1 = White 
2 = Black 
3 = Hispanic/Latino 
4 = Asian 
5 = Other (Alaskan Native, American Indian, multiracial, and people who 
refused to answer) 
 
Gender 1 = Male 
2 = Female 
 
Age 1 = 18-24 
2 = 25-34 
3 = 35-44 
4 = 45-54 
5 = 55-64 
6 = 65-above 
 
Health Insurance 
Status 
1 = Not covered 
2 = Covered 
 Region of U.S. 1 = Northeast 
2 = Midwest 
3 = South 
4 = West 
 
Marital Status 
 
1 = Married 
2 = Separated 
3 = Divorced 
4 = Single/never married 
5 = Widowed 
 Education 1 = Less than high school 
2 = High school diploma/GED 
3 = Some college (including associate’s degree) 
4 = Bachelor’s degree 
5 = Master’s degree or higher 
 Poverty to Income 
Ratio 
1 = Poor (family income is below U.S. poverty threshold) 
2 = Near poor (family income is 100% - < 200% of U.S. poverty 
threshold) 
3 = Not poor (family income is ≥ 200% of U.S. poverty threshold) 
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3.4 Statistical Analysis 
Descriptive statistics were created to describe the overall population sample.  To better 
understand the population with regards to each vaccine, descriptive tables were also produced 
per immunization type.  An odds ratio calculation was performed to test the association between 
receipt of each vaccine and the aforementioned social and demographic characteristics.  Using a 
binary logistic regression analysis, odds ratios were calculated along with 95% confidence 
intervals and p-values.  A p-value of less than 0.05 was considered a statistically significant 
association between the socio-demographic factor and the receipt of the vaccine. 
To further examine potential association between the dependent and independent 
variables, multivariate logistic regression analyses were performed for each vaccine where all 
socio-demographic factors were considered at once.  Odds ratios were once again calculated, 
along with 95% confidence intervals and the aforementioned accepted p-value of less than 0.05. 
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Chapter IV  
RESULTS 
 
4.1 Frequencies and Descriptive Statistics 
Frequency and descriptive statistics about the study sample are detailed in Table 2.  
Overall the sample size included 21,781 people; 56.3% were female and 43.7% were male.  
Caucasian people were the most represented race/ethnicity among the study population (61%) 
and Asian people were the least represented race/ethnicity (5.7%).  The delineation of “other” 
within the race/ethnicity category consisted of Alaskan Natives, American Indians, multiracial 
people, and people who refused to state their race/ethnicity.  For statistical purposes, the total N 
for this was group so small (1.2%) that the delineation will not be addressed in the results section 
of this examination.  While the study aimed to have an even representation of people from each 
region of the U.S., the South had the highest representation (36.9%).  For the purpose of this 
study, which focused on adults, all respondents were adults over the age of 18.  The age of 
participants was approximately evenly distributed except for the age range of 18-24 (9.8% - 
lowest) and the age range of 65-above (20.4% - highest).  Most respondents reported having 
some type of health insurance (83.2%).  Region of residence in the U.S. was lowest for the 
northeast (16.4%) and highest for the south (36.9%).  Almost half of the respondents were 
married (45.5%) and more than half had either high school or some college education (56.3%).  
With regards to the poverty to income ratio, the majority of the population fell into the not poor 
category (55.6%).  It should be noted that the poverty to income variable had the highest reported 
refused/don’t know delineation (11.7%).  This is because a large number of respondents either 
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refused to provide specific family income data or family income data in general, and the 
calculated poverty to income ratio processed by the 2008 NHIS depended on family income data.   
 
Table 2.  Socio-demographic characteristics of eligible adult subjects who completed the 2008 
NHIS 
Variable N Percent 
Overall total 21781 100 
Race   
     White 13289 61.0 
     Black 3365 15.4 
     Hispanic/Latino 3673 16.9 
     Asian 1238 5.7 
    Other* 216 1.0 
Gender   
     Male 9514 43.7 
     Female 12267 56.3 
Age   
    18-24 2130 9.8 
    25-34 3944 18.1 
    35-44 3947 18.1 
    45-54 3970 18.2 
    55-64 3346 15.4 
   65-above 4444 20.4 
Health Insurance status   
    Covered 18122 83.2 
    Not covered 3601 16.5 
    Refused/Don’t know 58 0.3 
Region   
    Northeast 3562 16.4 
    Midwest 4924 22.6 
    South 8033 36.9 
    West 5262 24.2 
Marital status   
    Separated 772 3.5 
    Divorced 3247 14.9 
    Married 9903 45.5 
    Single/never married 5613 25.8 
    Widowed 2159 9.9 
    Unknown 87 0.4 
Education   
    < High School 3749 17.2 
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    High School Diploma or GED 5853 26.9 
    Some college (incl. AA degree) 6399 29.4 
    Bachelor’s degree 3757 17.2 
    Master’s degree or higher 1874 8.6 
    Refused/Don’t know 149 0.7 
Poverty to Income Ratio**   
    Poor 2455 16.2 
    Near poor 2506 16.5 
    Not poor 8442 55.6 
    Refused/Don’t know 1769 11.7 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family 
income is below the poverty threshold; near poor=family income 100% - <200% of the poverty 
threshold; not poor = family income ≥200% of the poverty threshold. 
 
Frequency and descriptive statistics about the study sample’s vaccination status are 
detailed in Table 3.  In terms of immunization status, the tetanus vaccine had the highest 
prevalence rate (55.1% vaccinated) and the hepatitis A vaccine had the lowest prevalence rate 
(9.4%).  While most people reported they had not received hepatitis A or B vaccinations (82.4% 
and 66.6% respectively), for those who did receive hepatitis A and/or B vaccines, most of the 
respondents completed the required number of shots for each.  Of those who received the 
hepatitis A vaccine, 58.5% completed the series and of those who received hepatitis B vaccine, 
81.4% completed the series.  Just over half of the population received a tetanus shot in the past 
10 years (55.1%); however, most of these people were not sure if that shot also contained the 
pertussis vaccination (70.4%).  Finally, the majority of the population reported they had not 
received a pneumonia vaccination (76.9%).   
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Table 3.  Vaccination status of eligible adults who completed the 2008 NHIS 
Variable N Percent 
Overall total 21781 100 
Pneumonia shot   
    Yes 4199 19.3 
    No 16751 76.9 
    Refused/Don’t know 831 3.8 
Hepatitis A status (Ever)   
    Yes  2048 9.4 
    No  17944 82.4 
    Refused/Don’t know 1789 8.2 
If Hepatitis A status = yes, is series complete? N=2048  
    Complete series (≥2 shots) 1198 58.5 
    Incomplete series (<2 shots) 397 19.4 
    Refused/Don’t know 453 22.1 
Hepatitis B status (Ever)   
    Yes 5926 27.2 
    No 14497 66.6 
    Refused/Don’t Know 1358 6.3 
If Hepatitis B status = yes, is series complete? N=5926  
    Complete series (3 shots) 4824 81.4 
    Incomplete series (<3 shots) 724 12.2 
    Refused/Don’t know 378 6.4 
Tetanus shot past 10 years   
    Yes 12006 55.1 
    No 8474 38.9 
    Refused/Don’t know 1301 5.9 
If Tetanus shot = yes, did it include Pertussis? 12006 55.1 
    Yes 690 15.2 
    No 646 14.3 
    Don’t know 3189 70.4 
 
 
4.2 Pneumonia 
In the 2008 NHIS questionnaire, a total of 4,199 people reported receipt of the pneumococcal 
vaccination.  Characteristics associated with receipt of pneumococcal vaccine are shown in Table 
5.  The analysis of the independent variables indicated that all of the independent variables were 
significantly associated with receipt of pneumococcal vaccine; however, the strength of these 
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associations varied widely.  Each subcategory of the race/ethnicity variable was associated with 
receipt of pneumococcal disease vaccine; however, White people had the highest likelihood of 
receipt of the vaccine and Hispanic/Latino people had the lowest likelihood (OR = 0.315) which 
indicated they were 0.315 times less likely to receive the vaccine compared with the referent 
group (White).  With regards to gender, females were 1.23 times more likely to receive the 
vaccine than males.  Age range also played a significant role in odds of receiving the vaccine.  
People ≥45 were at least 2.16 times more likely to receive the vaccine than the referent group of 
18-24 years, and those ≥ 65 were 21.75 times more likely to receive the vaccine compared to the 
referent age (18-24 years). 
Socio-demographic variables analyzed included health insurance, region, marriage status, 
and reported levels of education.  The results are presented in Table 5.  As might be expected, 
those who reported having health insurance were 4.6 times more likely to receive the vaccine 
compared to those who did not report health insurance.  Residence per region of the U.S. was 
only significant for the west region, where people were 0.861 times less likely to receive the 
vaccine as compared to the referent group (northeast).  In terms of marital status, the only 
delineation not associated with receipt of the vaccine was those who were divorced.  Those who 
were widowed had the highest association with receipt of the vaccine, as they were 4.93 times 
more likely to receive the vaccine than any other marital status category (with married being the 
referent).  Those who were single/never married had the lowest association and were 0.439 times 
less likely to receive the vaccine compared to those who were married.  Education was only 
significantly associated for the some college and bachelors degree categories and overall those 
with less than a high school degree, the referent group, were the most likely to receive the 
vaccine.  People with some college were 0.81 times less likely to receive the vaccine as 
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compared to the referent group, and people with a bachelor’s degree were 0.582 times less likely 
to receive the vaccination.  In terms of poverty level, those who were either near poor or not poor 
had a higher chance of receiving the vaccine (OR = 1.49 and 1.19, respectively) versus those 
who were considered poor.  
Additional analysis of the factors influencing pneumococcal vaccine was performed by 
including all of the independent socio-demographic variables in a multivariate logistic regression 
model.  When adjusting for all other factors via the multivariate analysis, the results varied from 
the individual models and some independent variables were no longer significant.  Race/ethnicity 
outcomes remained similar in that White people were the most likely to receive the vaccine and 
Hispanic/Latino people were the least likely (OR = 0.555).  Gender was no longer a statistically 
significant factor that was associated with receipt of pneumococcal vaccines.  Age remained 
significant; however, a person’s odds of receipt of the vaccine began to increase at an earlier age 
of 35.  Elderly people aged ≥65 remained the most likely to receive the pneumococcal vaccine, 
as they were 19.24 times more likely to receive the vaccine as compared to the 18-24 year old 
age range. 
In terms of other socio-demographic variables, reported insurance coverage remained 
positively associated with receipt of the vaccine, as those with insurance were 1.71 times more 
likely to be vaccinated compared to those who did not report insurance coverage.  However, it 
should be noted that the strength of this association was much lower than what was noted before 
the data were adjusted for other factors (OR = 4.60).  Residence per region of the U.S. showed a 
different outcome versus the bivariate analysis:  when adjusting for all other factors, those who 
lived in the south were most likely to receive the vaccine (OR = 1.26) and residence in the west 
region was no longer a significant factor as compared to those who lived in the northeast 
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(referent group).  Marital status showed different results once data were adjusted for other 
factors, as none of the delineations were associated with receipt of the vaccine except for those 
who were widowed (OR = 1.36).  In terms of education level, after adjusting for all other factors 
the results indicated that only certain groups were more likely to receive the vaccine, whereas the 
bivariate results showed a decreased likelihood of vaccination for all education levels ≥ high 
school diploma/GED.  Those who completed some college were 1.24 times more likely to be 
vaccinated compared to those with less than high school education and those with a master’s 
degree or higher were 1.28 times more likely to be vaccinated.  When adjusting for all other 
factors, poverty level was no longer a significant predictor in terms of pneumococcal vaccine 
receipt. 
 
4.3 Hepatitis A 
In the 2008 NHIS questionnaire, a total of 2,048 people reported receipt of the hepatitis A 
vaccination.  Characteristics associated with receipt of hepatitis A vaccine are shown in Table 6.  
The analysis of the independent variables indicated that all of the independent variables were 
significantly associated with receipt of the hepatitis A vaccine except for gender and health 
insurance coverage.  With regards to race/ethnicity, Asians had the highest odds ratio and were 
1.79 times more likely to receive the vaccine as compared to Whites.  As age increased, the 
likelihood of hepatitis A vaccine receipt decreased.  In fact, all age ranges higher than the 
referent of 18-24 had a lower likelihood of vaccination. 
Socio-demographic variables analyzed are also presented in Table 6.  Those who lived in the 
west region of the U.S. were most likely to receive the vaccine (OR = 1.77) as compared to the 
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northeast referent group.  For marital status, the strongest association was for the single/never 
married population; they were 1.72 more likely to receive the vaccine as compared to those who 
were married.  Education level displayed a direct relationship; as education level increased, so 
did the likelihood of vaccine receipt.  Those with a masters degree or higher were the most likely 
to be vaccinated (OR = 3.47) as compared to those who did not complete high school.  Poverty to 
income ratio showed that those who were near poor were 0.748 times less likely to receive the 
vaccine versus those who were poor (referent). 
Additional analysis of the factors influencing hepatitis A vaccine was performed by including 
all of the independent socio-demographic variables in a multivariate logistic regression model.  
When adjusting for all other factors via the multivariate analysis, the results varied from the 
individual models.  Race/ethnicity was no longer a significant factor, and gender remained 
insignificant.  Those who were between the ages of 18-24 (referent) remained the most likely to 
receive the vaccine, and the inverse relationship of increased age to decreased vaccination odds 
remained. 
In terms of other socio-demographic variables, reported health insurance coverage remained 
positively associated with receipt of the vaccine, as those with health insurance were 1.31 times 
more likely to be vaccinated than those who didn’t report coverage.  People in the west region of 
the U.S. (OR = 1.70) remained more likely to be vaccinated than the referent group in the 
northeast region.  In terms of marital status, the only population with a significant result was the 
separated group; they had a slightly higher chance of being vaccinated (OR = 1.44) as compared 
to the married referent group.  Education remained significant with a direct relationship between 
increased education and increased vaccination rates.  Additionally, the education odds ratios for 
the multivariate analysis were higher than those for the bivariate analysis meaning once data 
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were adjusted for all other factors, education level became a stronger predictor of hepatitis A 
vaccination receipt.  Those with a masters degree or higher were 4.43 times more likely to be 
vaccinated as compared to those with a less than high school level education.  Poverty level was 
no longer a significant factor. 
 
4.4 Hepatitis B 
In the 2008 NHIS questionnaire, a total of 5,926 people reported receipt of the hepatitis B 
vaccination.  Characteristics associated with receipt of hepatitis B vaccine are shown in Table 7.  
The analysis of the independent variables indicated a significant association for all independent 
variables except health insurance status.  Using white people as the referent, Asian people were 
the most likely to receive the vaccine (OR = 1.41) and Hispanic/Latino people were the only 
group to have a lower likelihood of vaccine receipt (OR = 0.874).  Females were 1.30 times more 
likely to receive the hepatitis B vaccine as compared to males.  Age showed a direct, significant 
relationship in that as the population aged, they were less likely to receive the vaccine. 
Socio-demographic variables analyzed are also presented in Table 7.  The only region of the 
U.S. that indicated a significant association with receipt of the hepatitis B vaccine was the 
Midwest.  Residents in the Midwest were 1.25 times more likely to receive the vaccine as 
compared to those in the Northeast (referent).  Marital status results indicated that those who 
were single/never married had the highest likelihood of receiving the hepatitis B vaccine (OR = 
1.83) as compared to those who were married (referent).  Education level resulted in a 
significant, direct relationship and as education level increased, so did the chances of receiving 
the vaccine (with the exception of the bachelor degree category, however the numeric difference 
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was small).  Those with a master’s degree were the most likely to receive the vaccine (OR = 
3.25) as compared to those who did not complete high school (referent).  Those who were 
classified as near poor were less likely to receive the vaccine (OR = 0.791) as compared to those 
who were classified as poor (referent). 
Additional analysis of the factors influencing hepatitis B vaccine was performed by including 
all of the independent socio-demographic variables in a multivariate logistic regression model.  
When adjusting for all other factors via the multivariate analysis, the results varied from the 
individual models.  All factors were significant except for region and poverty to income ratio.  
Within the race/ethnicity variable, the only association that remained significant after adjusting 
for all other factors was for the Hispanic/Latino population; this group was 0.840 times less 
likely to receive the vaccine as compared to Whites.  The data showed that females were 1.45 
times more likely than males to receive the hepatitis B vaccine; a slightly higher odds ratio 
versus the individual model outcomes.  As the study population became older they also became 
less likely to receive the vaccine, with those ≥ 65 years showing the lowest odds ratio of 0.063 
compared to those 18-24 years of age. 
In terms of other socio-demographic variables, reported health insurance became a 
statistically significant predictor of hepatitis B vaccine receipt as compared to the individual 
model.  People who reported insurance coverage were 1.36 times more likely to receive the 
vaccine versus those without coverage.  Marital status was only a significant factor if the 
population was widowed, as those people were 0.692 times less likely to receive the vaccine as 
compared to those who were married (referent).  The association of the education variable 
remained consistent as per the individual model analysis; those with higher education were more 
likely to receive the vaccine.  People with a masters degree or higher were 3.77 times more 
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likely, and overall the most likely, to receive the vaccine versus people who did not have a high 
school education.     
 
4.5 Tetanus 
In the 2008 NHIS questionnaire, a total of 12,006 people reported receipt of the tetanus 
vaccination.  Characteristics associated with receipt of tetanus vaccine are shown in Table 8.  
The analysis of the independent variables indicated that all of the independent variables were 
significantly associated with receipt of the hepatitis B vaccine.  All race/ethnicities had a lower 
likelihood of receiving the tetanus vaccination as compared to White people; however, it should 
be noted that for this vaccine the race/ethnicity with the lowest likelihood of vaccination was the 
Asian population (OR = 0.402).  This is in contrast to most of the other vaccines, where the 
Hispanic/Latino population typically had the lowest likelihood of vaccine receipt as compared to 
the referent (White).  Females were 0.750 times less likely to receive the vaccine as compared to 
males.  Age was a significant factor overall, and the data showed that those who were above the 
age of 24 had a slightly lower likelihood of tetanus vaccination.  Those in the ≥ 65 category had 
the lowest likelihood of vaccination as compared to the referent (18-24), with an odds ratio of 
0.448. 
Socio-demographic variables were analyzed and are presented in Table 8.  As might be 
expected, people with reported health insurance coverage were 1.41 times more likely to be 
vaccinated against tetanus versus those without health insurance.  In the region of the U.S. 
variable, the only area with a significant association was the Midwest – that population was 1.54 
times more likely to receive the vaccine as compared to the referent group in the northeast.  
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Marital status did not prove to be a strong predictor of vaccine receipt except for those in the 
widowed population, as they were 0.549 times less likely to be vaccinated compared to the 
married population (referent).  Trends associated with education level were similar to many of 
the previous analyses in that as education level increased, so did the likelihood of tetanus 
vaccination.  Those with a masters degree or higher had the highest likelihood of tetanus 
vaccination (OR = 2.24) as compared to those who did not complete high school.  In terms of 
poverty to income ratio, those who were not poor were 1.47 times more likely to receive the 
tetanus vaccine as compared to those who were poor. 
Additional analysis of the factors influencing hepatitis B vaccine was performed by including 
all of the independent socio-demographic variables in a multivariate logistic regression model.  
When adjusting for all other factors via the multivariate analysis the results were similar to the 
individual model, with some minor variations.  All race/ethnicity categories had a lower 
likelihood of being vaccinated as compared to Whites, and those who were Asian were the least 
likely with an odds ratio of 0.402.  Females were less likely to receive the vaccine (OR = 0.770) 
as compared to males, and those with health insurance coverage were 1.42 times more likely to 
receive the vaccine as compared to those without health insurance coverage.  As the population 
aged, the odds of receiving a tetanus vaccine decreased and those who were ≥ 65 had the lowest 
likelihood of receiving the vaccine (OR = 0.320) versus the 18-24 year old referent group. 
In terms of other socio-demographic variables, residence in region of the U.S. was more 
significant for the multivariate model as compared to the individual model results.  Compared to 
the northeast (referent), residence in all other regions was associated with a higher likelihood of 
receipt of the tetanus vaccine.  The Midwest showed the strongest association with an odds ratio 
of 1.43.  Marital status was only significant for the single/never married and the widowed 
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populations; those groups were 0.836 and 0.832 times less likely (respectively) to be vaccinated 
as compared to the married population.  Higher education levels were associated with a higher 
likelihood of tetanus vaccination with the exception of the master’s degree or higher population, 
which was no longer a statistically significant factor.  Poverty to income ratio was significant for 
the not poor population, which had a slightly increased likelihood of vaccination (OR = 1.11) as 
compared to those who were poor. 
 
4.6 Pertussis 
In the 2008 NHIS questionnaire, a total of 690 people reported receipt of the pertussis 
vaccination.  This limited sample size created limitations with the data.  Characteristics 
associated with receipt of pertussis vaccine are shown in Table 9.  The analysis of the 
independent variables indicated that all of the independent variables were significantly 
associated with receipt of the pertussis vaccine except for gender, health insurance status, and 
region.  With regards to race/ethnicity, the only significant association was for those who were 
Asian; a population that was 1.86 times more likely to receive the vaccine as compared to White 
people.  Compared to the referent group of 18-24 year olds, as the population’s age increased its 
likelihood of receiving the pertussis vaccine decreased with an odds ratio range of 0.443-0.584 
though it should be noted the association for the 25-34 age range was not statistically significant. 
Results of the socio-demographic variables analyzed are presented in Table 9.  Compared to 
the referent group of married people, those who were single/never married were 1.31 times more 
likely to receive the vaccine.  All other marital status categories were not significantly 
associated.  Education level was only significantly associated for those who had a bachelor’s 
degree, as that population was 1.46 times more likely to have the pertussis vaccine compared to 
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people with less than a high school education.  Finally, those who were near poor were 0.622 
times less likely to receive the pertussis vaccine as compared to those who were poor. 
Additional analysis of the factors influencing pertussis vaccine was performed by including 
all of the independent socio-demographic variables in a multivariate logistic regression model.  
When adjusting for all other factors via the multivariate analysis, the number of variables with a 
significant association decreased.  Along with the insignificant factors of gender, health 
insurance status, and region, additional factors of race/ethnicity, marital status, and education 
level transitioned from significant to insignificant as compared to the individual model.  
Therefore, after adjusting for all other factors the only independent variables with a significant 
association were age and poverty to income ratio.  For age, those who were ≥ 35 years were 
between 0.450-0.522 times less likely to receive the pertussis vaccine as compared to the 18-24 
cohort (referent).  Finally, those who were near poor were 0.595 times less likely to receive the 
vaccine as compared to those who were poor. 
 
4.7 Consistent Significant Associations 
Table 4 shows a summary of the statistically significant demographic characteristics per the 
multivariate analyses performed in this examination.  Pertussis will be treated as an exception 
because, as mentioned earlier, the sample size was quite small (N=690).  Reasons for this 
challenging sample size will be addressed later in this study. 
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Table 4.  Summary of statistically significant demographic characteristics for each vaccine based 
on the multivariate analysis results 
 Vaccine 
Characteristic Pneumococcal Hepatitis A Hepatitis B Tetanus Pertussis 
Race      
Gender      
Age      
Health insurance      
Region      
Marital status      
Education      
Poverty to income ratio      
 
With the exception of the pertussis vaccine, the characteristics that showed as significant 
regardless of the vaccine type were age, health insurance, marital status, and education.  These 
results, especially age, health insurance, and education, follow suit with the previous research 
regarding social determinants of health. 
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Table 5.  Descriptive characteristics and bivariate versus multivariate analysis using logistic regression assessing the association of 
demographic characteristics with Pneumonia (N=4199) vaccine status in eligible adult subjects who completed the 2008 NHIS 
 Descriptive 
(received 
vaccine) 
Bivariate Multivariate 
Variable N (%) OR CI (95%) p-value OR CI (95%) p-value 
Race        
     White 3104 (73.9) REF REF REF REF REF REF 
     Black 540 (12.9) 0.625 0.565-0.691 <0.001 0.673 0.588-0.772 <0.001 
     Hispanic/Latino 361 (8.6) 0.354 0.315-0.397 <0.001 0.555 0.471-0.655 <0.001 
     Asian 147 (3.5) 0.443 0.371-0.529 <0.001 0.609 0.473-0.785 <0.001 
    Other* 47 (1.1) 0.928 0.668-1.29 0.654 1.31 0.841-2.04 0.233 
Gender        
     Male 1653 (39.4) REF REF REF REF REF REF 
     Female 2546 (60.6) 1.23 1.15-1.32 <0.001 1.06 0.961-1.17 0.247 
Age        
    18-24 118 (2.8) REF REF REF REF REF REF 
    25-34 190 (4.5) 0.838 0.662-1.06 0.144 0.894 0.644-1.24 0.502 
    35-44 265 (6.3) 1.19 0.947-1.48 0.138 1.55 1.13-2.12 0.007 
    45-54 458 (10.9) 2.16 1.75-2.67 <0.001 2.50 1.84-3.40 <0.001 
    55-64 707 (16.8) 4.49 3.66-5.50 <0.001 4.99 3.68-6.76 <0.001 
   65-above 2461 (58.6) 21.75 17.88-26.45 <0.001 19.24 14.21-26.05 <0.001 
Health Insurance status        
   Not covered 3984 (94.9) REF REF REF REF REF REF 
   Covered 209 (5.0) 4.60 3.98-5.32 <0.001 1.71 1.42-2.07 <0.001 
Region        
    Northeast 689 (16.4) REF REF REF REF REF REF 
    Midwest 993 (23.6) 1.05 0.937-1.17 0.431 1.15 0.991-1.33 0.065 
    South 1606 (38.2) 1.03 0.934-1.14 0.529 1.26 1.10-1.44 0.001 
    West 911 (21.7) 0.861 0.771-0.961 0.008 1.11 0.954-1.29 0.176 
Marital status        
    Married 1835 (43.7) REF REF REF REF REF REF 
    Separated 100 (2.4) 0.653 0.526-0.811 <0.001 1.05 0.817-1.36 0.690 
    Divorced 642 (15.3) 1.10 0.994-1.22 0.066 0.987 0.865-1.13 0.843 
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    Single/never married 501 (11.9) 0.439 0.395-0.487 <0.001 0.971 0.834-1.13 0.708 
    Widowed 1108 (26.4) 4.93 4.45-5.45 <0.001 1.36 1.18-1.57 <0.001 
Education        
    < High School 826 (19.7) REF REF REF REF REF REF 
    High School Diploma/GED 1238 (29.5) 0.944 0.854-1.04 0.260 1.04 0.896-1.20 0.635 
    Some college/2 year degree 1197 (28.5) 0.809 0.732-0.894 <0.001 1.24 1.07-1.44 0.005 
    Bachelor’s degree 534 (12.7) 0.582 0.516-0.656 <0.001 0.943 0.789-1.13 0.518 
    Master’s degree or higher 385 (9.2) 0.906 0.790-1.04 0.156 1.28 1.05-1.56 0.015 
Poverty to Income Ratio**        
    Poor 412 (13.1) REF REF REF REF REF REF 
    Near poor 588 (18.7) 1.49 1.30-1.72 <0.001 1.08 0.911-1.28 0.373 
    Not poor 1658 (52.8) 1.19 1.05-1.34 0.005 0.894 0.765-1.04 0.156 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family income is below the poverty threshold; 
near poor=family income 100% - <200% of the poverty threshold; not poor = family income ≥200% of the poverty threshold. 
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Table 6.  Descriptive characteristics and bivariate versus multivariate analysis using logistic regression assessing the association of 
demographic characteristics with Hepatitis A (N=2048) vaccine status in eligible adult subjects who completed the 2008 NHIS 
 Descriptive 
(received 
vaccine) 
Bivariate Multivariate 
Variable N (%) OR CI (95%) p-value OR CI (95%) p-value 
Race        
     White 1221 (59.6) REF REF REF REF REF REF 
     Black 304 (14.8) 0.997 0.873-1.14 0.960 0.989 0.837-1.17 0.897 
     Hispanic/Latino 315 (15.4) 0.954 0.837-1.09 0.478 0.840 0.697-1.01 0.068 
     Asian 178 (8.7) 1.79 1.51-2.13 <0.001 1.12 0.889-1.41 0.340 
    Other* 30 (1.5) 1.63 1.10-2.42 0.014 1.40 0.852-2.29 0.186 
Gender        
     Male 934 (45.6) REF REF REF REF REF REF 
     Female 1114 (54.4) 0.916 0.836-1.00 0.061 0.938 0.834-1.06 0.292 
Age        
    18-24 446 (21.8) REF REF REF REF REF REF 
    25-34 546 (26.7) 0.583 0.506-0.670 <0.001 0.525 0.432-0.638 <0.001 
    35-44 428 (20.9) 0.420 0.363-0.487 <0.001 0.367 0.295-0.456 <0.001 
    45-54 284 (13.9) 0.260 0.221-0.305 <0.001 0.226 0.178-0.286 <0.001 
    55-64 218 (10.6) 0.233 0.196-0.277 <0.001 0.196 0.152-0.253 <0.001 
   65-above 126 (6.2) 0.097 0.079-0.120 <0.001 0.097 0.072-0.132 <0.001 
Health Insurance status        
   Not covered 1711 (83.5) REF REF REF REF REF REF 
   Covered 332 (16.2) 1.01 0.893-1.15 0.860 1.31 1.11-1.56 0.002 
Region        
    Northeast 246 (12.0) REF REF REF REF REF REF 
    Midwest 451 (22) 1.35 1.15-1.58 <0.001 1.26 1.03-1.55 0.027 
    South 751 (36.7) 1.38 1.19-1.60 <0.001 1.47 1.21-1.77 <0.001 
    West 600 (29.3) 1.77 1.51-2.06 <0.001 1.70 1.39-2.08 <0.001 
Marital status        
    Married 879 (42.9) REF REF REF REF REF REF 
    Separated 83 (4.1) 1.26 0.993-1.60 0.057 1.44 1.10-1.89 0.009 
    Divorced 243 (11.9) 0.822 0.709-0.954 0.010 0.964 0.807-1.15 0.690 
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    Single/never married 775 (37.8) 1.72 1.55-1.91 <0.001 0.980 0.840-1.14 0.801 
    Widowed 62 (3.0) 0.296 0.228-0.385 <0.001 0.862 0.625-1.19 0.365 
Education        
    < High School 181 (8.8) REF REF REF REF REF REF 
    High School Diploma/GED 369 (18.0) 1.32 1.10-1.58 0.003 1.62 1.25-2.09 <0.001 
    Some college/2 year degree 744 (36.3) 2.62 2.21-3.10 <0.001 2.60 2.04-3.32 <0.001 
    Bachelor’s degree 472 (23.0) 2.88 2.41-3.44 <0.001 2.94 2.25-3.82 <0.001 
    Master’s degree or higher 275 (13.4) 3.47 2.85-4.23 <0.001 4.43 3.33-5.89 <0.001 
Poverty to Income Ratio**        
    Poor 257 (18.4) REF REF REF REF REF REF 
    Near poor 207 (14.8) 0.748 0.616-0.907 0.003 0.863 0.702-1.06 0.161 
    Not poor 834 (59.8) 0.910 0.784-1.06 0.211 0.856 0.716-1.02 0.087 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family income is below the poverty threshold; 
near poor=family income 100% - <200% of the poverty threshold; not poor = family income ≥200% of the poverty threshold. 
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Table 7.  Descriptive characteristics and bivariate versus multivariate analysis using logistic regression assessing the association of 
demographic characteristics with Hepatitis B (N=5926) vaccine status in eligible adult subjects who completed the 2008 NHIS 
 Descriptive 
(received 
vaccine) 
Bivariate Multivariate 
Variable N (%) OR CI (95%) p-value OR CI (95%) p-value 
Race        
     White 3588 (60.5) REF REF REF REF REF REF 
     Black 968 (16.3) 1.09 1.00-1.19 0.048 1.10 0.985-1.23 0.089 
     Hispanic/Latino 889 (15.0) 0.874 0.802-0.952 0.002 0.840 0.740-0.953 0.007 
     Asian 412 (7.0) 1.41 1.24-1.60 <0.001 1.08 0.907-1.29 0.378 
    Other* 69 (1.2) 1.32 0.982-1.77 0.066 1.07 0.724-1.57 0.749 
Gender        
     Male 2306 (38.9) REF REF REF REF REF REF 
     Female 3620 (61.1) 1.30 1.22-1.38 <0.001 1.45 1.34-1.58 <0.001 
Age        
    18-24 1164 (19.6) REF REF REF REF REF REF 
    25-34 1567 (26.4) 0.525 0.470-0.586 <0.001 0.428 0.366-0.501 <0.001 
    35-44 1197 (20.2) 0.338 0.302-0.379 <0.001 0.252 0.213-0.298 <0.001 
    45-54 953 (16.1) 0.241 0.215-0.271 <0.001 0.177 0.149-0.210 <0.001 
    55-64 654 (11.0) 0.183 0.161-0.207 <0.001 0.141 0.117-0.170 <0.001 
   65-above 391 (6.6) 0.072 0.063-0.083 <0.001 0.063 0.051-0.078 <0.001 
Health Insurance status        
   Not covered 4952 (83.6) REF REF REF REF REF REF 
   Covered 957 (16.1) 1.04 0.954-1.12 0.406 1.36 1.21-1.52 <0.001 
Region        
    Northeast 888 (15.0) REF REF REF REF REF REF 
    Midwest 1464 (24.7) 1.25 1.14-1.38 <0.001 1.09 0.962-1.25 0.171 
    South 2170 (36.6) 1.09 0.992-1.91 0.075 1.01 0.892-1.13 0.931 
    West 1404 (23.7) 1.09 0.988-1.20 0.085 0.971 0.852-1.11 0.655 
Marital status        
    Married 2524 (42.6) REF REF REF REF REF REF 
    Separated 225 (3.8) 1.22 1.04-1.44 0.018 1.20 0.987-1.45 0.067 
    Divorced 834 (14.1) 1.01 0.917-1.10 0.918 1.07 0.958-1.21 0.219 
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    Single/never married 2131 (36.0) 1.83 1.71-1.97 <0.001 0.900 0.807-1.00 0.057 
    Widowed 197 (3.3) 0.286 0.245-0.333 <0.001 0.692 0.571-0.839 <0.001 
Education        
    < High School 571 (9.6) REF REF REF REF REF REF 
    High School Diploma/GED 1256 (21.2) 1.52 1.36-1.70 <0.001 1.60 1.37-1.86 <0.001 
    Some college/2 year degree 2162 (36.5) 2.87 2.59-3.19 <0.001 2.56 2.21-2.98 <0.001 
    Bachelor’s degree 1242 (21.0) 2.82 2.52-3.16 <0.001 2.50 2.12-2.95 <0.001 
    Master’s degree or higher 678 (11.4) 3.25 2.85-3.71 <0.001 3.77 3.13-4.54 <0.001 
Poverty to Income Ratio**        
    Poor 728 (17.9) REF REF REF REF REF REF 
    Near poor 638 (15.7) 0.791 0.697-0.897 <0.001 0.960 0.832-1.11 0.579 
    Not poor 2382 (58.7) 0.915 0.828-1.01 0.083 0.930 0.819-1.06 0.258 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family income is below the poverty threshold; 
near poor=family income 100% - <200% of the poverty threshold; not poor = family income ≥200% of the poverty threshold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
Table 8.  Descriptive characteristics and bivariate versus multivariate analysis using logistic regression assessing the association of 
demographic characteristics with Tetanus (N=12006) vaccine status in eligible adult subjects who completed the 2008 NHIS 
 Descriptive 
(received 
vaccine) 
Bivariate Multivariate 
Variable N %) OR CI (95%) p-value OR CI (95%) p-value 
Race        
     White 8002 (66.7) REF REF REF REF REF REF 
     Black 1611 (13.4) 0.582 0.538-0.630 <0.001 0.643 0.583-0.709 <0.001 
     Hispanic/Latino 1721 (14.3) 0.555 0.514-0.599 <0.001 0.657 0.590-0.730 <0.001 
     Asian 532 (4.4) 0.493 0.436-0.557 <0.001 0.402 0.342-0.473 <0.001 
    Other* 140 (1.2) 1.21 0.901-1.63 0.205 1.11 0.784-1.58 0.546 
Gender        
     Male 5603 (46.7) REF REF REF REF REF REF 
     Female 6403 (53.3) 0.750 0.709-0.794 <0.001 0.770 0.716-0.828 <0.001 
Age        
    18-24 1339 (11.2) REF REF REF REF REF REF 
    25-34 2241 (18.7) 0.711 0.634-0.797 <0.001 0.591 0.504-0.694 <0.001 
    35-44 2233 (18.6) 0.698 0.623-0.783 <0.001 0.549 0.464-0.648 <0.001 
    45-54 2335 (19.4) 0.770 0.687-0.864 <0.001 0.554 0.467-0.656 <0.001 
    55-64 1861 (15.5) 0.685 0.609-0.771 <0.001 0.482 0.404-0.574 <0.001 
   65-above 1997 (16.6) 0.448 0.400-0.501 <0.001 0.320 0.267-0.382 <0.001 
Health Insurance status        
   Not covered 10227 (85.2) REF REF REF REF REF REF 
   Covered 1753 (14.6) 1.41 1.31-.152 <0.001 1.42 1.29-1.58 <0.001 
Region        
    Northeast 1833 (15.3) REF REF REF REF REF REF 
    Midwest 3033 (25.3) 1.54 1.40-1.68 <0.001 1.43 1.28-1.60 <0.001 
    South 4295 (35.8) 1.05 0.966-1.14 0.254 1.13 1.02-1.25 0.020 
    West 2845 (23.7) 1.09 0.993-1.19 0.072 1.20 1.08-1.35 0.001 
Marital status        
    Married 5670 (47.2) REF REF REF REF REF REF 
    Separated 417 (3.5) 0.866 0.744-1.01 0.063 1.07 0.899-1.28 0.441 
    Divorced 1843 (15.4) 0.982 0.904-1.07 0.674 0.976 0.882-1.08 0.631 
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    Single/never married 3135 (26.1) 0.970 0.905-1.04 0.384 0.836 0.757-0.924 <0.001 
    Widowed 901 (7.5) 0.549 0.498-0.605 <0.001 0.832 0.730-0.948 0.006 
Education        
    < High School 1611 (13.4) REF REF REF REF REF REF 
    High School 
Diploma/GED 
3121 (26.0) 1.53 1.40-1.66 <0.001 1.33 1.19-1.48 <0.001 
    So e college/2 year 
degree 
3865 (32.2) 2.08 1.91-2.27 <0.001 1.64 1.47-1.84 <0.001 
    Bachelor’s degree 2202 (18.3) 1.96 1.78-2.15 <0.001 1.79 1.53-2.09 <0.001 
    Master’s degree or higher 1157 (9.6) 2.24 1.99-2.52 <0.001 0.821 0.452-1.49 0.517 
Poverty to Income Ratio**        
    Poor 1215 (14.7) REF REF REF REF REF REF 
    Near poor 1289 (15.6) 1.07 0.952-1.20 0.264 1.05 0.931-1.19 0.422 
    Not poor 4973 (60.1) 1.47 1.34-1.61 <0.001 1.11 0.998-1.24 0.053 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family income is below the poverty threshold; 
near poor=family income 100% - <200% of the poverty threshold; not poor = family income ≥200% of the poverty threshold. 
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Table 9.  Descriptive characteristics and bivariate versus multivariate analysis using logistic regression assessing the association of 
demographic characteristics with Pertussis (N=690) vaccine status in eligible adult subjects who completed the 2008 NHIS 
 Descriptive 
(received 
vaccine) 
Bivariate Multivariate 
Variable N (%) OR CI (95%) p-value OR CI (95%) p-value 
Race        
     White 453 (65.7) REF REF REF REF REF REF 
     Black 113 (16.4) 1.35 0.992-1.84 0.056 1.21 0.815-1.79 0.346 
     Hispanic/Latino 86 (12.5) 1.14 0.814-1.59 0.452 1.08 0.689-1.70 0.735 
     Asian 31 (4.5) 1.86 1.01-3.40 0.045 1.37 0.587-3.21 0.465 
    Other* 7 (1.0) 1.19 0.396-3.56 0.759 0.501 0.120-2.08 0.341 
Gender        
     Male 278 (40.3) REF REF REF REF REF REF 
     Female 412 (59.7) 1.24 0.996-1.54 0.054 1.02 0.770-1.35 0.894 
Age        
    18-24 109 (15.8) REF REF REF REF REF REF 
    25-34 171 (24.8) 0.695 0.473-1.02 0.063 0.601 0.352-1.03 0.061 
    35-44 153 (22.2) 0.584 0.398-0.858 0.006 0.522 0.293-0.929 0.027 
    45-54 158 (22.9) 0.535 0.366-0.782 0.001 0.519 0.290-0.930 0.028 
    55-64 99 (14.3) 0.443 0.295-0.667 <0.001 0.450 0.239-0.847 0.013 
   65-above -- -- -- -- -- -- -- 
Health Insurance status        
   Not covered 595 (86.2) REF REF REF REF REF REF 
   Covered 94 (13.6) 1.08 0.793-1.47 0.625 1.12 0.743-0.169 0.586 
Region        
    Northeast 92 (13.3) REF REF REF REF REF REF 
    Midwest 166 (24.1) 0.970 0.678-1.39 0.868 1.05 0.665-1.66 0.833 
    South 265 (38.4) 1.21 0.864-1.70 0.266 1.33 0.862-2.05 0.198 
    West 167 (24.2) 1.06 0.740-1.52 0.745 1.04 0.660-1.64 0.865 
Marital status        
    Married 320 (46.4) REF REF REF REF REF REF 
    Separated 26 (3.8) 0.978 0.559-1.71 0.938 1.27 0.660-2.46 0.470 
    Divorced 100 (14.5) 0.986 0.719-1.35 0.930 1.09 0.742-1.61 0.653 
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    Single/never married 229 (33.2) 1.31 1.02-1.69 0.032 0.970 0.676-1.39 0.871 
    Widowed 13 (1.9) 0.943 0.436-2.04 0.943 1.02 0.435-2.38 0.968 
Education        
    < High School 54 (7.8) REF REF REF REF REF REF 
    High School Diploma/GED 133 (19.3) 1.02 0.666-0.156 0.932 0.862 0.483-1.54 0.616 
    Some college/2 year degree 270 (39.1) 1.46 0.977-2.17 0.065 1.22 0.703-2.13 0.477 
    Bachelor’s degree 154 (22.3) 1.59 1.04-2.45 0.034 1.55 0.845-2.86 0.156 
    Master’s degree or higher 75 (10.9) 1.43 0.878-0.233 0.150 1.43 0.731-2.80 0.296 
Poverty to Income Ratio**        
    Poor 75 (16.4) REF REF REF REF REF REF 
    Near poor 70 (15.3) 0.622 0.389-0.995 0.048 0.595 0.365-0.972 0.038 
    Not poor 294 (64.2) 0.776 0.529-1.14 0.193 0.780 0.499-1.22 0.276 
*defined as Alaskan Native, American Indian, multiracial, and people who refused to answer 
**based on reported income and the U.S. Census Bureau poverty threshold.  Poor = family income is below the poverty threshold; 
near poor=family income 100% - <200% of the poverty threshold; not poor = family income ≥200% of the poverty threshold. 
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Chapter V  
DISCUSSION AND CONCLUSION 
 
5.1 Discussion 
Vaccine preventable diseases can cause significant deaths, chronic symptoms, and 
increased health care costs among the adult population (Trust for America's Health, 2010).  
Additionally, as adults become infected with certain preventable diseases they pose an increased 
risk to surrounding children who may not be fully vaccinated (André, 2003).  Even though safe 
and effective vaccines to protect against a variety of diseases exist, many adults remain either un-
vaccinated or under-vaccinated.  In fact, worldwide more adults die from vaccine-preventable 
diseases as compared to children (Baeyens, 2010).  In order to address low vaccination rates for 
vaccine preventable diseases a search for literature showed that physician and practitioner driven 
reminder systems have been a primary focus of research (Trust for America's Health, 2010; E. 
Uskun, S. B. Uskun, Uysalgenc, & Yagiz, 2008; Zimmerman et al., 2008).  Research regarding 
physician and practitioner reminder systems suggests enhanced patient reminder systems would 
result in a more vaccinated adult population over time (E. Uskun et al., 2008).  While this 
concept is important, patient reminder systems cannot be the sole solution.  They do not account 
for the portion of the adult population who is either uninsured or not seeing the same healthcare 
provider for each visit, and reminder systems do not address the disparities amongst different 
socio-demographic characteristics. 
The purpose of this work was to examine the potential association of specific socio-
demographic characteristics with the receipt of adult optional vaccines.  Previous public health 
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research has revealed a variety of social determinants of health which have been shown to 
directly affect a person’s health (U.S. Department of Health and Human Services, 2000).  These 
determinants, which include but are not limited to race/ethnicity, age, and education level, are 
malleable and can be overcome (Kovner & Knickman, 2008; Turnock, 2009; U.S. Department of 
Health and Human Services, 2000).  A better understanding of the characteristics that describe 
the vaccinated portion of the population is needed in order to address these aforementioned 
socio-demographic disparities and in order to eliminate them.  As a better understanding of the 
characteristics of the vaccinated adult population is gained, public health and healthcare 
professionals will be able to implement more informed and targeted interventions aimed at 
increasing adult vaccination rates.  As the U.S. achieves its immunization goals the population 
will become more protected and healthier. 
 
Race/Ethnicity 
Race/ethnicity, while not a factor consistently associated with the receipt of adult 
vaccines in this study, is an important factor to consider.  Results regarding the relationship 
between race/ethnicity varied depending on the vaccine.  The pneumococcal and tetanus 
vaccines followed patterns established in preexisting literature where the highest likelihood of 
medical care in general was for White people and all other groups had a decreased likelihood of 
medical care (Adult Immunization Consensus Panel, 2003; N. A. Daniels, Juarbe, Moreno-John, 
& Pérez-Stable, 2007; N. A. Daniels et al., 2004; Nowalk et al., 2006).  In this study, the odds of 
receiving both of these vaccines were lower for all other races/ethnicities as compared to the 
White population.  On the other hand, the results for the analysis of the race/ethnicity variable 
with respect to the prevalence of hepatitis B vaccine receipt indicated that no race/ethnicity 
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groups were significantly associated with vaccine receipt except for the Hispanic/Latino 
population; a group that was 0.840 times less likely to receive the vaccine.  Results for hepatitis 
A and pertussis did not display significant relationships for the race/ethnicity variable. Reasons 
why some vaccines exhibited racial disparities and others did not are unclear; additional research 
is needed.  
In general, the results from this analysis suggested that none of the race/ethnicity groups 
were as likely to receive vaccines as the White population.  This finding complimented the trends 
already noted in many social determinants studies:  those who are White tend to have either 
better health or at the very least, fewer disparities to overcome with regards to health (Adult 
Immunization Consensus Panel, 2003; U.S. Department of Health and Human Services, 2000).  
While receipt of optional vaccines may not serve as a causal pathway to what one would 
consider improved health, it is reasonable to relate the concepts of vaccines and better health 
since a person who is more vaccinated is therefore at less risk for disease.  Along with studies 
that have shown Whites have better health overall, existing literature has also stated that 
differences in health outcomes across race/ethnicity groups is in part due to the types of 
healthcare providers each race utilizes as well as the training of each provider and the resources 
he or she offers (Fiscella & Holt, 2007; Zimmerman et al., 2008).  These provider variations 
were not part of the NHIS data, but could be an underlying factor related to race-related vaccine 
differences. 
The results from this analysis also showed that after adjusting for other variables and 
assessing statistical significance the Hispanic/Latino population was less likely to receive 
vaccines with the exception of the hepatitis A and pertussis vaccines (both were not significant).  
The lack of significance may be due to smaller sample sizes and lower prevalence of vaccination 
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compared to the other vaccines’ prevalence rates.  It is also potentially explained by results from 
previous public health studies where minorities, specifically Blacks and Hispanics/Latinos, often 
have lower health statuses than Whites (Adult Immunization Consensus Panel, 2003; Callahan & 
Cooper, 2004; U.S. Department of Health and Human Services, 2000).  For the data used in this 
study, it is unclear whether the lower likelihood of vaccination for the Hispanic/Latino 
population was due to language barriers versus other factors such as cultural differences or types 
of providers commonly utilized.  Future research should be conducted to consider the 
Hispanic/Latino population’s vaccination rates along with possible language barriers, differences 
in access to health care, potential differences regarding patterns of use of health care, 
accessibility issues such as lack of transportation and additional accessibility access challenges 
such as a person’s normal working hours versus hours of operation at clinics and vaccine-
providing facilities. 
 
Gender 
Gender was only significant for the hepatitis B and tetanus vaccines.  Females were more 
likely to receive the hepatitis B vaccine as compared to males and one possible reason for this 
association is because of gender trends in health care professions.  The hepatitis B is either 
occupationally mandated or strongly recommended for certain jobs such as those in the health 
care industry due to the increased risk from bodily fluid/blood contact (Immunization Action 
Coalition, 2009).  In general, one could safely make the observation that health care provision 
(for example, nursing) is often a female dominated profession so it would make sense that the 
data indicated a higher likelihood of hepatitis B vaccination for females.  Since occupation was 
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not included in the analysis, it is not possible to analyze the role of occupation in this study, but 
it deserves further research in the future. 
On the other hand, females were less likely to receive the tetanus vaccine as compared to 
males.  This result is interesting since tetanus vaccination and decennial tetanus boosters are 
recommended for everyone, regardless of gender and regardless of a profession within health 
care (Heymann, 2008; Rhee, Nunley, Demetriades, Velmahos, & Doucet, 2005).  Tetanus is not 
a common disease in the U.S. due to better sanitary conditions as well as a strong immunization 
program (Rhee et al., 2005).  People often receive additional tetanus boosters when they endure 
an unexpected injury, but it should be noted that this vaccination does not remove the potential 
for tetanus infection from the current injury; it simply protects against future infections (Rhee et 
al., 2005).  It would seem that the association between adult injuries and adult tetanus vaccines 
would result in  a higher likelihood of vaccination for men since men are more often found doing 
occupations and hobbies that are higher in risk (Leigh, Waehrer, Miller, & McCurdy, 2006).  
However, the exact reasons for a lower likelihood of female tetanus vaccinations are unclear and 
more research is needed in order to explore this association. 
 
Age 
Age influenced vaccination prevalence differently for different vaccinations.  For the 
tetanus, hepatitis A, hepatitis B, and pertussis vaccines the data indicated that those between the 
ages of 18-24 had the highest likelihood of vaccine receipt.  Since certain vaccines (such as 
tetanus and hepatitis B) are required for school aged people the higher prevalence of vaccine 
receipt among this age group is linked to these requirements.  For example, most schools and 
universities in the U.S. do not allow students to matriculate unless they have received a tetanus 
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booster within the past ten years (MMWR, Centers for Disease Control and Prevention, 2006).  
Furthermore, because tetanus, pertussis, and hepatitis B are now routine childhood vaccinations 
there is a higher likelihood of these vaccines in the young adult population (Atkinson et al., 
2009; Heymann, 2008; MMWR, Centers for Disease Control and Prevention, 2006).  An adapted 
chart detailing recommended child and adolescent immunizations per age is shown in Figure 3, 
below. 
 
Figure 3. Recommended child and adolescent immunization schedule, 2010 
Age Hepatitis A Hepatitis B Diptheria/Tetanus/Pertussis 
Birth  1
st
 dose  
2 Months  
2
nd
 dose (1-2 
months) 
DTaP 
4 Months   DTaP 
6 Months  
3
rd
 dose (6-18 
months) 
DTaP 
12 Months 
2 doses 
administered 6 
months apart age 
12-23 months 
 
15 Months 
DTaP 
18 Months 
19-23 Months 
(catch up as 
needed) 
 
4-6 Years 
(catch up as 
needed) 
DTaP 
7-10 Years  
11-12 Years Tdap 
13-18 Years  
   (Adapted from the Immunization Action Coalition website, 2010) 
 
For the pneumococcal vaccine, there was an opposite age trend in that as people aged, 
they were more likely to receive the vaccine.  In fact, people ≥ 65 had the highest likelihood of 
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receipt of the vaccine and were almost 20 times more likely to be vaccinated than the youngest 
age group.  This strong association is likely explained by the strong recommendation for 
pneumococcal vaccine in those ≥ 65 as a mechanism to reduce the disease (Heymann, 2008; 
Peetermans & Lacante, 1999). 
 
Access to Health Insurance 
Access to insurance was positively associated with receipt of each vaccine addressed in 
this study.  Those who reported some form of access to health insurance were between 1.12 
(pertussis) and 1.71 (pneumococcal) times more likely to be vaccinated.  These results align with 
previous research which has discussed the association between health insurance and either health 
status or vaccine status (Callahan & Cooper, 2004; Dombkowski, Lantz, & Freed, 2004; Hannan, 
Buchanan, & Monroe, 2009).  In fact, it has even been stated that lack of insurance can lead not 
only to lower health status, but also to longer periods of no healthcare as well as less screening 
and preventive care (Chou, Johnson, Ward, & Blewett, 2009). 
The literature indicates that for most children who reside in the U.S., cost is not a 
significant factor when addressing vaccine rates since most children are either covered via 
private insurance plans or federal programs such as Vaccines for Children (Hannan et al., 2009).  
This is an important finding to consider because there is no similar vaccine program for adults, 
especially for the optional vaccines discussed in this examination.  Many adults in the U.S. are 
uninsured, as displayed in this study where 16.5% of the population included in the analysis here 
reported no form of health insurance.  Previous studies cite similar levels for the U.S. 
populations citing approximately 15.9% of the population or one in six people were uninsured 
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(Center on Budget and Policy Priorities, 2006; Newport & Mendes, 2009).  Given that there is no 
adult version of the Vaccines for Children program, the adult U.S. population is at risk for lower 
vaccine rates; especially those who do not have insurance and/or the financial means to pay for 
such vaccines.  While this study cannot explain the precise reasons why health insurance is a 
strong predictor of vaccine receipt it can be hypothesized that rationales such as cost, access, and 
patient reminders are probable. 
 
Region of the U.S. 
This independent variable did not yield any trends that could show an overall association 
between region and likelihood of adult vaccination receipt.   People who lived in the South were 
the most likely to receive the pneumococcal, hepatitis A, and pertussis vaccines while people 
who lived in the Midwest were most likely to receive the hepatitis B and tetanus vaccines.  
Interestingly, when using the Northeast as the referent group, all other regions had a higher 
likelihood of receipt of vaccine except for hepatitis B where the West had the lowest likelihood.  
There is no clear explanation for these outcomes, as the literature did not state any of the 
vaccines noted in this examination were either more or less encouraged per region of the U.S.  
Region of the U.S. might be a proxy for other factors which predict adult vaccination, so this 
variable is difficult to interpret without further analysis. 
It is possible that a more appropriate variable for this examination could have been 
residence in an urban versus rural area instead of the region of the U.S.  There is ample literature 
that discusses both the challenges and benefits of living in these different types of environments.  
For example, urban areas tend to have problems with overcrowding and air pollution, but on the 
other hand they sometimes have better access to resources (Frumkin, 2005).  Rural areas do not 
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always encompass overcrowding and pollution challenges, but because of their sprawling 
landscape there is often an issue with access to medical care which is nearby (Frumkin, 2005).  
With that said, it should be noted that using an urban versus rural independent variable for this 
particular dataset would require more complete income information than what was obtained for 
the 2008 NHIS.  This would ensure income was neither a confounder nor an effect modifier in 
terms of association strength. 
 
Marital Status 
Marital status, while not initially a factor one would intuitively assume could 
significantly affect vaccination status, was a significant factor for all vaccines aside from 
pertussis.  In a 2008 study, marital status (more specifically, marital trajectories and timing) was 
compared with mortality rates in U.S. adults and it was suggested that those who are 
separated/divorced suffer the most negative health outcomes due to stress, loss of income, 
emotional distress, and significant and sometimes unexpected changes in daily life (Dupre, Beck, 
& Meadows, 2009).  In the same study it was also suggested that those who are widowed, endure 
multiple marriage dissolutions (divorce or widowhood), and those who are married at a young 
age (<18) have a higher likelihood of negative health outcomes, including mortality, overall 
(Dupre et al., 2009). 
The trends noted in this examination do not completely agree with the Dupre et al. study 
from 2009, because some vaccines showed lower likelihood of vaccination with the unmarried 
marital statuses (hepatitis A, tetanus) and other vaccines showed higher likelihood of vaccination 
with the unmarried marital statuses (hepatitis B, pneumonia – except for widowed category).  It 
is possible that for diseases easily transmitted via sexual contact (such as hepatitis B) marital 
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status might a stronger, clearer association with vaccine receipt as compared to diseases which 
are not transmitted sexually; in other words, people who are not married might have more sexual 
partners, be at higher risk for sexually transmitted diseases, and choose to receive vaccines for 
preventive reasons.  Rationales for this possible idea as well as reasons for the marital status 
trends in this examination are unclear.  It is also possible that either age or occupational trends 
could be explanations for these results, but more research is needed in order to better address the 
association.  
In terms of pneumococcal vaccines, those who were widowed were more likely to receive 
the vaccine.  It is plausible that this is because we can assume more elderly people are widowed 
as compared to younger people.  Therefore, because this vaccine is intended primarily for elderly 
persons, the data showed a strong association between vaccine status and widowed status.  
Similarly, the tetanus vaccination data showed that those who were single/never married had the 
highest likelihood of vaccine receipt as compared to those who were married.  Once again this 
can be related to age trends.  Much of the single/never married population likely falls within the 
younger age ranges which are the same populations who are more likely to be in school and 
therefore required to receive the vaccine. 
 
Education 
In this examination the overall results indicated that as education level increased, so did 
the likelihood of additional adult vaccinations.  In fact, for most vaccines addressed the results 
showed that those with a master’s or professional degree had the highest likelihood of vaccine 
receipt as compared to both the referent group (less than a high school education) as well as all 
other levels of education lower than a master’s or professional degree.  This result supports 
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social determinant of health theories which state that education level is a good predictor of health 
and that as people become more educated they tend to be in better health (Kawachi, Adler, & 
Dow, 2010). 
Research has also proven that as people become more educated they tend to have better 
access to healthcare (Callahan & Cooper, 2004).  Therefore, education level affects one’s health 
in multiple ways, as it acts in synergy with access to insurance and thus, access to care.  The 
analyses performed did not address why people with a higher level of education tended to have 
higher prevalence of the vaccines examined in this study.  It is possible that this is due to 
increased knowledge of health indicators, more knowledge and support of the concept related to 
the need for and benefit of preventive healthcare, and possibly better access to care via employer 
sponsored insurance, but data from the 2008 NHIS were not collected regarding these ideas.  
Finally, one should not ignore the possibility that in this study, higher education levels might 
have been proxies for socio-economic status since higher education levels could plausibly 
indicate better paying jobs. 
 
Poverty to Income Ratio 
Results from this study showed that once data were adjusted for all other factors, 
differences between those who were poor, near poor, and not poor were largely insignificant.  
The only association found to be statistically significant for receipt of vaccines was the 
relationship between the near poor population and the pertussis vaccine.  The results suggested 
that those who were near poor were 0.60 times less likely to receive the vaccine as compared to 
those who were classified into the poor category.  While this is a somewhat counterintuitive 
result, it is possible this near poor population was neither financially stable enough to afford 
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vaccines (lack of insurance, lack of income) nor poor enough to qualify for government funded 
healthcare and benefits.  However, the sample was small and possibly difficult to generalize to 
the overall population of interest.   
As mentioned earlier, the lack of associations for poverty to income ratio and prevalence 
of vaccination was most likely due to the fact that this variable was weak in terms of data.  The 
number of questionnaire respondents who refused to provide family income data was quite large, 
which caused an answer of “refused/don’t know” for 11.7% the poverty to income ratio statistic, 
and many of the people who were willing to provide the information would only do so via 
increments of $50,000.  Therefore the income data was either largely missing or vague.  It is 
unclear whether the data would have shown more associations had the income data been 
stronger.  In general the literature suggests that overall, those who are either poor or near poor 
typically have lower levels of access to healthcare and poorer levels of overall health (Flory, 
Joffe, Fishman, Edelstein, & Metlay, 2009; U.S. Department of Health and Human Services, 
2000; Zimmerman et al., 2009).  Therefore, it would be expected that this variable would be an 
important indicator in prevalence of vaccines.  However, without either a better understanding of 
this measure or perhaps more accurate income data, this association within the 2008 NHIS data 
remains unclear.  Additional research related to poverty level and adult vaccine receipt is needed. 
 
5.2 Study Limitations 
This examination encountered multiple limitations that are important to acknowledge.  
First, the design of the study created some challenges.  Because the study was cross-sectional, 
the associations between socio-demographic characteristics and vaccine receipt could be 
assessed; however, the study design was not strong enough to enable an analysis of direct 
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causation for these factors and vaccine prevalence.  Second, the NHIS data for this study were 
self-reported and therefore errors due to recall bias were both possible and unavoidable. 
Another limitation was sample size.  While overall sample size was not a challenge for 
this study, it became challenging for the pertussis portion, as the total number of people who 
stated they had ever received the pertussis vaccine was 690.  The 2008 NHIS questionnaire 
linked tetanus and pertussis together, so if a respondent reported receipt of a tetanus shot within 
the past 10 years, s/he was asked if that shot also contained the pertussis vaccine.  If respondents 
did not receive a tetanus vaccine in the past 10 years, they were not asked about pertussis.  This 
questionnaire pattern is a potential reason why the pertussis sample was so low.  Additionally, 
the majority of people who were asked of their pertussis vaccine status answered “don’t know” 
which resulted in a large portion of unusable pertussis data. 
As mentioned earlier, data related to family income were largely incomplete.  Per 
statements from the NHIS, income information was hard to collect from survey participants 
resulting in a lot of missing information.  Because income data was used to calculate the poverty 
to income ratio (PIR), both the income and the PIR data were therefore not as strong as they 
could have been.  This lack of family income data could also be why some inconsistencies within 
the PIR numbers existed.  Along with the need for more complete family income data, there was 
also a need for vaccine cost data.  No data related to either the cost of vaccines or to people’s 
attitudes about the cost of vaccines were collected.  It would have been helpful to know if cost, 
either actual or perceived, acted as a barrier to vaccine receipt. 
Another limitation was the lack of information about respondents’ religious beliefs, 
sexual orientation, and current student status.  Religion would have been helpful to include in the 
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NHIS questionnaire because religious beliefs can be very important when one considers use of 
health care.  It is possible that religious beliefs could have had a significant impact on overall 
vaccine prevalence in the 2008 NHIS data.  Sexual orientation would have been helpful to 
include, as it is one of the primary social determinants noted in the Healthy People 2010 report.  
Additionally, some vaccines such as hepatitis B are strongly recommended for specific sexual 
orientations (D. Daniels et al., 2009; Heymann, 2008; Immunization Action Coalition, 2009).  
Furthermore, in a 2009 study it was shown that significant differences in access to healthcare 
exist between homosexual and heterosexual people in the U.S. (Buchmueller & Carpenter, 
2010).  It would have been helpful to know if those who are at higher risk were either 
appropriately or under-vaccinated.  Finally, knowing whether each respondent was either a 
current student or in a certain line of work would have been beneficial, as this information could 
have helped to either prove or disprove that some of the population was vaccinated because they 
were required due to current student and/or occupation status. 
One final limitation to be addressed was related to the education variable.  In this 
examination, the education groupings from the original dataset were altered for ease of data 
comparison.  Those with associate’s degrees were placed into the “some college” population so 
that those who had completed a four year degree (bachelor’s degree) could be analyzed.  As 
such, in some of the multivariate results the trajectory of increased vaccination likelihood with 
increased education level was slightly skewed for the some college category.  Even though 
overall the data showed that as education level increased, so did the chances of being vaccinated, 
the some college category often displayed a slightly higher odds ratio as compared to the 
bachelor’s degree category.  It is possible that those who completed associates degrees should 
have been combined with the bachelor’s degrees population.   
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5.3 Recommendations  
Additional research is needed to address the limitations noted above, as well as to expand 
the available literature related to the socio-demographic characteristics associated with receipt of 
optional adult vaccines.  Specifically, an additional study that addresses behavioral aspects of 
vaccination receipt choices would be helpful to expand the literature beyond socio-demographic 
factors.  For example, it would be helpful to know if healthier habits overall (i.e. non smokers, 
people with lower body mass indexes, people who utilize preventive health care regularly, 
people who engage in regular physical activity, etc.) lead to more vaccinations. 
Also, additional studies to address whether a specific type of health insurance leads to a 
change in vaccination status would be helpful.  This would allow researchers, policy makers, and 
health professionals the opportunity to develop and implement interventions aimed at resolving 
these differences.  More research related to insurance type differences could also better 
illuminate the disparities among different socio-economic statuses.  For example, it is possible 
that people covered by Medicaid have higher vaccination rates as compared to people with 
private insurance.  Or, it is even more possible that some vaccinations are covered by certain 
types of insurance whereas other types of insurance treat those same vaccines as out of pocket 
expenses.  These are questions that are not easily answered via a review of current literature. 
Another focus for additional research is related to patient reminder systems.  It would be 
helpful to know if reminder systems vary depending on each type of health care provider or type 
of insurance.  Also related to patient reminder systems and patient knowledge is the issue of the 
pertussis vaccine and the fact that the majority of the people who received a tetanus vaccine in 
the past 10 years did not know if that shot also contained the pertussis vaccine.  There must be a 
way to ensure that more people are aware of the health care they receive.  Some research related 
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to take-home patient records exists, but more is needed in order to create a stronger need for 
interventions moving forward.   
The results for the tetanus vaccine showed that as age increased likelihood of vaccination 
decreased overall, especially after the age of 54.  More research is needed to try and identify why 
this trend exists.  Clearly the efforts implemented to encourage receipt of the pneumonia vaccine 
for people ≥ 65 have worked, as evidenced by the results in the current and previous studies.  It 
is possible that these types of targeted efforts could be used for the ≥55 population with regards 
to tetanus. 
Finally, the U.S. must find a way to better educate the public (both patients and 
providers) about the benefits of and the need for immunizations against vaccine preventable 
diseases.  These efforts must include multi-lingual outreach methods, especially for those who 
are Hispanic/Latino.  The Hispanic/Latino population was the least vaccinated overall in this 
study, yet the majority of the literature states that Blacks tend to have the least access to 
healthcare.  While no minority should ever be ignored, it is abundantly clear from the data 
reviewed in this examination that the Hispanic/Latino population is at a much higher risk of 
preventable diseases.  Reasons for this higher risk need to be identified and addressed 
 
5.4 CONCLUSION 
In the current era of waning primary care physicians and exponential numbers of 
specialists (Kovner & Knickman, 2008), it is imperative that preventive care not be overlooked.  
One could hypothesize that as more adults see specialists, less adults receive the routine care that 
tends to include vaccination discussions.  For example, if a large percent of the U.S. population 
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sees only specialists (only a gynecologist, only a physical therapist), education about the 
importance of immunizations might not be passed along to those patients since information about 
optional vaccines is not a typical office visit discussion.  Therefore, following the 
recommendations from current research regarding increasing healthcare providers’ awareness of 
vaccine preventable diseases could indeed be an effective solution.  For those specialists who 
might normally never address a pneumococcal or tetanus vaccine, the introduction of vaccine 
importance at their practice and subsequently to their patients could be the only time those 
patients become educated and aware.  However, this approach must not be the sole solution to 
increasing adult vaccine rates for preventable diseases since it will not account for those who are 
affected by the aforementioned disparities in age, gender, race, and so forth. 
Public health professionals, healthcare providers, policy makers, and the general 
population must all understand what factors cause adults to either receive or decline optional 
vaccines.  There is no genetic reason why Hispanic/Latino people, less educated people, lower 
income people, or different marital statuses should be less vaccinated and at higher risk for 
VPDs.  The U.S. must find a way to either remove or counteract these disparities.  And, while 
variables such as age or increased risk due to preexisting conditions cannot be reversed, they are 
factors that can be accounted for via public service announcements and better outreach.  Better 
knowledge of socio-demographic factors associated with receipt of adult, optional vaccines is 
imperative for stronger interventions and subsequent improved vaccination rates. 
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